<!DOCTYPE html>
<html lang="en">
<head>
<meta name="robots" content="noindex, nofollow">
<meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1">
<title>News Coverage — Judicialização da Saúde</title>
<style>
  :root {
    --bg: #f8f9fa; --card: #fff; --fg: #1a1a1a; --muted: #666;
    --border: #dee2e6; --accent: #0d6efd; --accent2: #198754;
  }
  * { box-sizing: border-box; margin: 0; padding: 0; }
  body {
    font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, sans-serif;
    background: var(--bg); color: var(--fg); line-height: 1.5;
  }

  main { padding: 1.5rem 2rem 3rem; max-width: 900px; margin: 0 auto; }

  .filters { margin-bottom: 1.2rem; display: flex; gap: .4rem; flex-wrap: wrap; }
  .filters button {
    font-size: .75rem; padding: .25rem .6rem; cursor: pointer;
    background: var(--card); border: 1px solid var(--border); border-radius: 4px;
    color: var(--muted); font-weight: 500; font-family: inherit;
  }
  .filters button:hover { border-color: var(--accent); color: var(--accent); }
  .filters button.active { background: var(--accent); color: #fff; border-color: var(--accent); }

  .story-count { font-size: .8rem; color: var(--muted); margin-bottom: 1rem; }

  .story {
    background: var(--card); border: 1px solid var(--border); border-radius: 6px;
    padding: 1rem 1.2rem; margin-bottom: .6rem;
  }
  .story-meta {
    display: flex; gap: .6rem; align-items: center; margin-bottom: .3rem;
    font-size: .75rem; color: var(--muted);
  }
  .story-meta .date { font-weight: 600; }
  .story-meta .outlet { }
  .story-meta .theme {
    font-size: .68rem; font-weight: 600; text-transform: uppercase;
    padding: .1rem .4rem; border-radius: 3px;
    background: #e7f1ff; color: var(--accent); letter-spacing: .02em;
  }
  .story h3 {
    font-size: .92rem; font-weight: 600; margin-bottom: .3rem;
  }
  .story h3 a { color: var(--fg); text-decoration: none; }
  .story h3 a:hover { color: var(--accent); }
  .story .summary { font-size: .83rem; color: #444; line-height: 1.55; }

  footer {
    text-align: center; padding: 1.5rem; font-size: .8rem; color: var(--muted);
    border-top: 1px solid var(--border); margin-top: 2rem;
  }
</style>
</head>
<body>

<style>
  .site-nav {
    position: sticky; top: 0; z-index: 100;
    background: #212529; display: flex; align-items: center;
    padding: 0 2rem; height: 3rem;
  }
  .site-nav .nav-brand {
    color: #fff; text-decoration: none; font-weight: 600; font-size: 1rem;
    margin-right: auto;
  }
  .site-nav .nav-brand:hover { color: #e9ecef; }
  .site-nav .nav-link {
    color: #adb5bd; text-decoration: none; font-size: .85rem;
    padding: 0 .75rem; height: 3rem; display: flex; align-items: center;
    background: none; border: none; cursor: pointer; font-family: inherit;
  }
  .site-nav .nav-link:hover, .site-nav .nav-link.active { color: #fff; }
  .nav-dropdown { position: relative; }
  .dropdown-menu {
    display: none; position: absolute; top: 3rem; right: 0;
    background: #fff; border: 1px solid var(--border); border-radius: 6px;
    box-shadow: 0 4px 16px rgba(0,0,0,.12); min-width: 220px;
    padding: .4rem 0; z-index: 200; max-height: 80vh; overflow-y: auto;
  }
  .nav-dropdown.open .dropdown-menu { display: block; }
  .dropdown-menu a {
    display: block; padding: .3rem 1rem; color: #1a1a1a;
    text-decoration: none; font-size: .82rem;
  }
  .dropdown-menu a:hover { background: #f0f4f8; }
  .dropdown-group-label {
    padding: .4rem 1rem .15rem; font-size: .68rem; font-weight: 700;
    color: #888; text-transform: uppercase; letter-spacing: .04em;
  }
  .dropdown-divider { border-top: 1px solid #eee; margin: .3rem 0; }
  .page-header {
    padding: .8rem 2rem; border-bottom: 1px solid var(--border); background: #fff;
  }
  .page-header h1 { font-size: 1.3rem; font-weight: 600; }
  .page-header p { color: var(--muted); font-size: .85rem; margin-top: .15rem; }
</style>

<nav class="site-nav">
  <a href="../index.html" class="nav-brand">Judicialização da Saúde</a>
  <a href="../paper/index.html" class="nav-link">Paper</a>
  <div class="nav-dropdown">
    <button class="nav-link">Docs &#9662;</button>
    <div class="dropdown-menu">
    <div class="dropdown-group-label">Research reference</div>
    <a href="../docs/README.html">Project Overview</a>
    <a href="../docs/summary.html">Research Summary</a>
    <a href="../docs/institutions.html">Institutional Background</a>
    <a href="../docs/data.html">Data Sources</a>
    <a href="../docs/methods.html">Empirical Methods</a>
    <a href="../docs/literature.html">Literature</a>
    <a href="../docs/theory.html">Theoretical Framework</a>
    <a href="../docs/hypotheses.html">Hypotheses & Evidence</a>
    <div class="dropdown-divider"></div>
    <div class="dropdown-group-label">Working notes</div>
    <a href="../docs/thinking.html">Open Questions & Ideas</a>
    <a href="../docs/decisions.html">Key Decisions</a>
    <a href="../docs/qa.html">Research Q&A</a>
    <div class="dropdown-divider"></div>
    <div class="dropdown-group-label">Task tracking</div>
    <a href="../docs/todo.html">Active Tasks</a>
    <a href="../docs/done.html">Completed Tasks</a>
    <div class="dropdown-divider"></div>
    <div class="dropdown-group-label">Communication</div>
    <a href="../docs/meetings.html">Meeting Notes</a>
    <a href="../docs/feedback.html">External Feedback</a>
    <div class="dropdown-divider"></div>
    <div class="dropdown-group-label">Court analysis</div>
    <a href="../docs/01-stf-reasoning-templates.html">STF Reasoning Templates</a>
    <a href="../docs/02-stj-repetitivos-patterns.html">STJ Repetitivos Patterns</a>
    <a href="../docs/03-tjsp-plans-vs-sus.html">TJSP: Plans vs SUS</a>
    <a href="../docs/04-conitec-pcdt-vs-courts.html">CONITEC vs Courts</a>
    <a href="../docs/05-interfederative-responsibility.html">Interfederative Responsibility</a>
    </div>
  </div>
  <div class="nav-dropdown">
    <button class="nav-link">Data &#9662;</button>
    <div class="dropdown-menu">
    <a href="../sources/tjsp.html">TJSP</a>
    <a href="../sources/datajud.html">DataJud</a>
    <a href="../sources/stf-stj.html">STF & STJ</a>
    <a href="../sources/trf3.html">TRF3</a>
    <a href="../sources/spending.html">Municipal Spending</a>
    <a href="../sources/legislation.html">Health Legislation</a>
    </div>
  </div>
  <a href="../references/index.html" class="nav-link">References</a>
  <a href="../news/index.html" class="nav-link active">News</a>
</nav>
<script>
document.querySelectorAll('.nav-dropdown > .nav-link').forEach(function(btn) {
  btn.addEventListener('click', function(e) {
    e.stopPropagation();
    var dd = btn.parentElement;
    var wasOpen = dd.classList.contains('open');
    document.querySelectorAll('.nav-dropdown.open').forEach(function(d) { d.classList.remove('open'); });
    if (!wasOpen) dd.classList.add('open');
  });
});
document.addEventListener('click', function() {
  document.querySelectorAll('.nav-dropdown.open').forEach(function(d) { d.classList.remove('open'); });
});
</script>

<div class="page-header">
  <h1>News Coverage</h1>
  <p>Media reporting on health judicialization in Brazil.</p>
</div>

<main>
<div class="filters" id="filters">
  <button class="active" data-theme="all">All</button>
  <button data-theme="institutional_response">Institutional Response (21)</button>
  <button data-theme="budget_pressure">Budget Pressure (20)</button>
  <button data-theme="individual_cases">Individual Cases (16)</button>
  <button data-theme="pharma_industry">Pharma Industry (16)</button>
  <button data-theme="equity">Equity (9)</button>
  <button data-theme="admin_failure">Admin Failure (8)</button>
  <button data-theme="procurement_cost">Procurement Cost (8)</button>
  <button data-theme="municipal_adaptation">Municipal Adaptation (8)</button>
  <button data-theme="crowd_out">Crowd-Out (6)</button>
  <button data-theme="enforcement">Enforcement (5)</button>
  <button data-theme="defensoria_access">Defensoria Access (5)</button>
  <button data-theme="political_economy">Political Economy (5)</button>
  <button data-theme="judge_perspective">Judge Perspective (3)</button>
  <button data-theme="conitec_politics">CONITEC Politics (3)</button>
</div>
<div class="story-count" id="story-count"></div>
<div id="stories">
<div class="story" data-theme="admin_failure">
  <div class="story-meta">
    <span class="date">2026-02-04</span>
    <span class="outlet">O Tempo</span>
    <span class="theme">Admin Failure</span>
  </div>
  <h3><a href="https://www.otempo.com.br/cidades/2026/2/4/paciente-em-risco-de-rompimento-de-aneurisma-esta-ha-quase-100-dias-internada-sem-cirurgia-no-sus-mg" target="_blank" rel="noopener">Paciente em risco de rompimento de aneurisma esta ha quase 100 dias internada sem cirurgia no SUS-MG</a></h3>
  <div class="summary">Elizabete Fernandes, 44, hospitalized 100 days in MG with cerebral aneurysm risk. Hospital lacked SUS credentialing for endovascular surgery. Transfer via CINT Belo Horizonte ordered Dec 3 but never executed. Lawsuit seeks judicial fund seizure for private surgery.</div>
</div>
<div class="story" data-theme="individual_cases">
  <div class="story-meta">
    <span class="date">2026-01-06</span>
    <span class="outlet">Tribuna Online</span>
    <span class="theme">Individual Cases</span>
  </div>
  <h3><a href="https://tribunaonline.com.br/cidades/pais-conseguem-na-justica-remedio-para-o-filho-que-custa-r-7-milhoes-287302" target="_blank" rel="noopener">Pais conseguem na Justica remedio para o filho que custa R$ 7 milhoes</a></h3>
  <div class="summary">After seven months of legal battle, parents obtained Zolgensma (~R$7 million) through SUS. Son now feeds himself, speaks, sits, stands with support.</div>
</div>
<div class="story" data-theme="crowd_out">
  <div class="story-meta">
    <span class="date">2026-01-04</span>
    <span class="outlet">Tribuna de Minas</span>
    <span class="theme">Crowd-Out</span>
  </div>
  <h3><a href="https://tribunademinas.com.br/noticias/cidade/04-01-2026/perspectiva-2026-saude.html" target="_blank" rel="noopener">Perspectivas 2026: Municipio encara desafios na Saude e tenta reduzir filas e sobrecarga</a></h3>
  <div class="summary">Juiz de Fora (MG) led MG ranking for judicial injunctions on hospitalization/ICU beds. Health Secretary described judicialization as a 'break in the regular flow of bed regulation.' Primary care shows long waits, doctor shortages.</div>
</div>
<div class="story" data-theme="individual_cases">
  <div class="story-meta">
    <span class="date">2025-12-29</span>
    <span class="outlet">Diario do Grande ABC</span>
    <span class="theme">Individual Cases</span>
  </div>
  <h3><a href="https://www.dgabc.com.br/Noticia/4276806/mae-luta-na-justica-para-manter-tratamento-do-filho-" target="_blank" rel="noopener">Mae luta na Justica para manter tratamento do filho</a></h3>
  <div class="summary">Mother fights to maintain Voxzogo (R$1 million/year) for son Antonio with achondroplasia. Treatment began after judicial decision; son began walking. STF suspended supply; mother fears developmental regression.</div>
</div>
<div class="story" data-theme="institutional_response">
  <div class="story-meta">
    <span class="date">2025-12-29</span>
    <span class="outlet">Portal CNJ</span>
    <span class="theme">Institutional Response</span>
  </div>
  <h3><a href="https://www.cnj.jus.br/uso-de-notas-tecnicas-para-embasar-decisoes-judiciais-em-saude-cresce-cerca-de-32-em-2025/" target="_blank" rel="noopener">Uso de notas tecnicas para embasar decisoes judiciais em saude cresce cerca de 32% em 2025</a></h3>
  <div class="summary">NAT-Jus technical notes grew 32% in 2025 (~131000 vs ~99000 in 2024). e-NatJus system now houses over 394000 technical notes total. Indicates increased judicial consultation of medical evidence following Tema 1234 decision.</div>
</div>
<div class="story" data-theme="budget_pressure">
  <div class="story-meta">
    <span class="date">2025-12-12</span>
    <span class="outlet">O Globo</span>
    <span class="theme">Budget Pressure</span>
  </div>
  <h3><a href="https://oglobo.globo.com/patrocinado/dino/noticia/2025/12/12/judicializacao-soma-149-dos-custos-dos-planos-de-saude-1.ghtml" target="_blank" rel="noopener">Judicializacao soma 1.49% dos custos dos planos de saude</a></h3>
  <div class="summary">ANS data: judicial costs = R$3.9B in Q1 2025 (1.49% of total expenses). Tripled since 2020 (R$1.2B/0.65%). 62% of judicial demands involve procedures already in mandatory coverage. Operators earned R$7.1B profit in Q1 2025 (+114% vs 2024). 231k new lawsuits against plans Aug 2024-Jul 2025.</div>
</div>
<div class="story" data-theme="budget_pressure">
  <div class="story-meta">
    <span class="date">2025-12-02</span>
    <span class="outlet">Camara dos Deputados</span>
    <span class="theme">Budget Pressure</span>
  </div>
  <h3><a href="https://www.camara.leg.br/noticias/1228954-judicializacao-da-saude-consome-r-184-bilhao-com-dez-medicamentos-mais-caros" target="_blank" rel="noopener">Judicializacao da saude consome R$ 1,84 bilhao com dez medicamentos mais caros</a></h3>
  <div class="summary">R$1.84 billion spent on just ten judicially ordered medications. R$2.7 billion annual bill equals one-third of Mais Medicos, nearly half of Brasil Sorridente, one-fifth of immunization program, and the entire SAMU budget -- serving only 6,000 patients.</div>
</div>
<div class="story" data-theme="institutional_response">
  <div class="story-meta">
    <span class="date">2025-11-07</span>
    <span class="outlet">Portal CNJ</span>
    <span class="theme">Institutional Response</span>
  </div>
  <h3><a href="https://www.cnj.jus.br/diagnostico-do-cnj-aponta-alto-indice-de-procedencia-e-baixa-conciliacao-em-acoes-de-saude/" target="_blank" rel="noopener">Diagnostico do CNJ aponta alto indice de deferimento de pedidos em saude e baixa conciliacao</a></h3>
  <div class="summary">CNJ diagnostic: ~600,000 health lawsuits filed Jan 2024 - Aug 2025. Six states show injunction approval rates above 85%. Conciliation rates below 1% in 17 states.</div>
</div>
<div class="story" data-theme="institutional_response">
  <div class="story-meta">
    <span class="date">2025-11</span>
    <span class="outlet">TJSC</span>
    <span class="theme">Institutional Response</span>
  </div>
  <h3><a href="https://www.tjsc.jus.br/web/imprensa/-/tjsc-expande-emissao-de-notas-tecnicas-por-meio-do-natjus-para-as-112-comarcas" target="_blank" rel="noopener">TJSC expande emissao de notas tecnicas por meio do NatJus para as 112 comarcas</a></h3>
  <div class="summary">Santa Catarina expanding NatJus to all 112 municipalities by Nov 2025 (pilot March 2025). Evidence-based notes via telehealth professionals from Funmed.</div>
</div>
<div class="story" data-theme="enforcement">
  <div class="story-meta">
    <span class="date">2025-11</span>
    <span class="outlet">Cidadeverde</span>
    <span class="theme">Enforcement</span>
  </div>
  <h3><a href="https://cidadeverde.com/noticias/445355/tce-multa-ex-prefeito-dr-pessoa-por-descumprir-decisao-sobre-recursos-da-saude" target="_blank" rel="noopener">TCE multa ex-prefeito Dr. Pessoa por descumprir decisao sobre recursos da saude</a></h3>
  <div class="summary">TCE-PI fined Teresina ex-mayor 5,000 UFR-PI for non-compliance with health budget precautionary measures during 2023. Mayor failed to present defense or prove compliance. Shows audit courts also enforce health spending rules.</div>
</div>
<div class="story" data-theme="individual_cases">
  <div class="story-meta">
    <span class="date">2025-10</span>
    <span class="outlet">Revista Forum</span>
    <span class="theme">Individual Cases</span>
  </div>
  <h3><a href="https://revistaforum.com.br/revista-forum/ajude-natalia-pimenta-dirigente-do-pco-luta-contra-leucemia-rara/" target="_blank" rel="noopener">Ajude Natalia Pimenta: dirigente do PCO luta contra leucemia rara</a></h3>
  <div class="summary">Natalia (40) in ICU with rare leukemia needed Revumenib. Injunction denied because drug lacks ANVISA registration. Only proven treatment option -- supporters argue formality violates human dignity.</div>
</div>
<div class="story" data-theme="institutional_response">
  <div class="story-meta">
    <span class="date">2025-09-18</span>
    <span class="outlet">Correio Braziliense</span>
    <span class="theme">Institutional Response</span>
  </div>
  <h3><a href="https://www.correiobraziliense.com.br/direito-e-justica/2025/09/7249899-judicializacao-da-saude-um-ano-do-julgamento-do-tema-1234-do-stf.html" target="_blank" rel="noopener">Judicializacao da saude: um ano do julgamento do Tema 1234 do STF</a></h3>
  <div class="summary">One-year retrospective: SUS lawsuits declined ~6-7% in H1 2025. NatJus notes for non-incorporated drugs up 40%. Union reimbursement claims rose 878%. National Health Platform delivered to CNJ Jan 2026 (15 months post-decision). Supplementary health lawsuits rose 7% (opposite direction).</div>
</div>
<div class="story" data-theme="institutional_response">
  <div class="story-meta">
    <span class="date">2025-09-04</span>
    <span class="outlet">ConJur</span>
    <span class="theme">Institutional Response</span>
  </div>
  <h3><a href="https://www.conjur.com.br/2025-set-04/judicializacao-da-saude-stf-precisou-reforcar-a-aplicacao-das-sumulas-vinculantes-60-e-61/" target="_blank" rel="noopener">STF precisou reforcar a aplicacao das Sumulas Vinculantes 60 e 61</a></h3>
  <div class="summary">STF intervened twice in 2025 to enforce compliance with Tema 1234. Problems: judges ordering direct patient reimbursement (now prohibited); courts not enforcing PMVG price ceiling; CMED needing updated sanctions. Recommended expanding judicial education on health matters.</div>
</div>
<div class="story" data-theme="institutional_response">
  <div class="story-meta">
    <span class="date">2025-09</span>
    <span class="outlet">Defensoria Publica RJ</span>
    <span class="theme">Institutional Response</span>
  </div>
  <h3><a href="https://www.defensoria.rj.def.br/noticia/detalhes/31975-Camara-de-Resolucao-de-Litigios-em-Saude-comemora-12-anos" target="_blank" rel="noopener">Camara de Resolucao de Litigios em Saude comemora 12 anos</a></h3>
  <div class="summary">RJ CRLS (2013-2025): analyzed 201,700+ requests, 57.52% resolved without litigation. Extrajudicial resolution rate climbed from ~35% (2013-14) to ~63% (2022-23). Savings of at least R$3.5 million.</div>
</div>
<div class="story" data-theme="defensoria_access">
  <div class="story-meta">
    <span class="date">2025-09</span>
    <span class="outlet">DPE-AM</span>
    <span class="theme">Defensoria Access</span>
  </div>
  <h3><a href="https://defensoria.am.def.br/2025/09/15/defensoria-celebra-dois-anos-da-crels-am-com-mais-de-r-12-milhoes-economizados-e-925-de-resolutividade/" target="_blank" rel="noopener">Defensoria celebra dois anos da CRELS com R$ 12 milhoes economizados e 92.5% de resolutividade</a></h3>
  <div class="summary">Amazonas CRELS (health litigation resolution chamber): 4,278 demands handled in 2 years, 92.5% resolution rate, R$12.5M saved. Meanwhile DPE-AM has deficit of 80 positions, budget frozen since 2021 at 0.69% of state budget.</div>
</div>
<div class="story" data-theme="crowd_out">
  <div class="story-meta">
    <span class="date">2025-08-17</span>
    <span class="outlet">Fala Voce Noticias</span>
    <span class="theme">Crowd-Out</span>
  </div>
  <h3><a href="https://www.falavoce.com.br/noticias/1359-2025/08/17/governo-gasta-r-2-73-bilhoes-com-medicamentos-fornecidos-por-decisoes-judiciais-em-2024" target="_blank" rel="noopener">Governo gasta R$ 2,73 bilhoes com medicamentos fornecidos por decisoes judiciais em 2024</a></h3>
  <div class="summary">In 2024, Ministry spent R$3.2 billion on judicial medication demands: R$1.9 billion from own budget + R$1.3 billion in reimbursements. 70% of five-year spending went to just ten medications.</div>
</div>
<div class="story" data-theme="budget_pressure">
  <div class="story-meta">
    <span class="date">2025-08</span>
    <span class="outlet">Diario do Para</span>
    <span class="theme">Budget Pressure</span>
  </div>
  <h3><a href="https://diariodopara.com.br/noticias/brasil/ministerio-saude-paga-r-27-bilhoes-com-medicamentos-judicializados-e-teme-explosao-de-custos" target="_blank" rel="noopener">Ministerio Saude paga R$ 2,7 bilhoes com medicamentos judicializados e teme explosao de custos</a></h3>
  <div class="summary">Ministry of Health spent R$2.73 billion on judicially ordered medications in 2024, up from R$1.8 billion in 2022 (50% increase in two years). Gene therapy Elevidys (R$14.6 million/patient) could cause cost explosion -- R$3 billion estimated for 213 patients with active lawsuits.</div>
</div>
<div class="story" data-theme="budget_pressure">
  <div class="story-meta">
    <span class="date">2025-08</span>
    <span class="outlet">Regiao News</span>
    <span class="theme">Budget Pressure</span>
  </div>
  <h3><a href="https://www.regiaonews.com.br/sidrolandia-ms/municipio-banca-mais-de-80-dos-gastos-com-medicamentos-e-judicializacao-ja-soma-r-1-milhao-em-2025" target="_blank" rel="noopener">Municipio banca mais de 80% dos gastos com medicamentos e judicializacao ja soma R$ 1 milhao em 2025</a></h3>
  <div class="summary">Small municipality of Sidrolandia (MS) spent R$1.016 million on judicially ordered medications in first 8 months of 2025, bearing 82% of costs. Receives only R$46,900/month in transfers but spends R$219,700/month of own funds.</div>
</div>
<div class="story" data-theme="budget_pressure">
  <div class="story-meta">
    <span class="date">2025-08</span>
    <span class="outlet">Folha de S.Paulo</span>
    <span class="theme">Budget Pressure</span>
  </div>
  <h3><a href="https://www.noticiasaominuto.com.br/brasil/2308762/ministerio-saude-paga-r-2-7-bilhoes-com-medicamentos-judicializados-e-teme-explosao-de-custos" target="_blank" rel="noopener">Ministerio da Saude paga R$ 2.7 bilhoes com medicamentos judicializados e teme explosao de custos</a></h3>
  <div class="summary">R$1.8B (2022) to R$2.73B (2024) rising ~R$400M/year. Elevidys: R$14.6M/dose ANVISA registration suspended but courts still ordering. R$3B needed for 213 active Elevidys lawsuits. Conitec rejected: gains dont exceed corticosteroids. Zolgensma risk-sharing March 2025.</div>
</div>
<div class="story" data-theme="budget_pressure">
  <div class="story-meta">
    <span class="date">2025-05-27</span>
    <span class="outlet">Agencia Brasil</span>
    <span class="theme">Budget Pressure</span>
  </div>
  <h3><a href="https://agenciabrasil.ebc.com.br/saude/noticia/2025-05/judicializacao-representa-um-terco-dos-gastos-estaduais-com-remedios" target="_blank" rel="noopener">Judicializacao representa um terco do gasto estadual com medicamentos</a></h3>
  <div class="summary">IPEA study: judicialized medication spending averaged 32.9% of total state medication budgets in 2023. New health lawsuits jumped from 76,836 in 2020 to 162,046 in 2024 (110.9% increase).</div>
</div>
<div class="story" data-theme="budget_pressure">
  <div class="story-meta">
    <span class="date">2025-05</span>
    <span class="outlet">IPEA</span>
    <span class="theme">Budget Pressure</span>
  </div>
  <h3><a href="https://www.ipea.gov.br/portal/categorias/45-todas-as-noticias/noticias/15830-judicializacao-corresponde-a-quase-33-dos-gastos-em-medicamentos-de-estados-brasileiros" target="_blank" rel="noopener">Judicializacao corresponde a quase 33% dos gastos em medicamentos de estados brasileiros</a></h3>
  <div class="summary">Municipalities increased medication spending by 40% vs 2019 while federal transfers fell 21% and state transfers fell 22%. Small municipalities (under 5,000 inhabitants) had highest per capita judicial medication cost at R$81.75.</div>
</div>
<div class="story" data-theme="procurement_cost">
  <div class="story-meta">
    <span class="date">2025-05</span>
    <span class="outlet">Gov.br / Secom</span>
    <span class="theme">Procurement Cost</span>
  </div>
  <h3><a href="https://www.gov.br/secom/pt-br/assuntos/noticias/2025/05/sus-realiza-primeiras-aplicacoes-do-zolgensma-medicamento-de-r-7-milhoes-para-criancas-com-ame" target="_blank" rel="noopener">SUS realiza primeiras aplicacoes do Zolgensma via acordo de compartilhamento de risco</a></h3>
  <div class="summary">SUS began providing Zolgensma (~R$7M) through innovative risk-sharing agreement: payment only if treatment is effective. Brazil secured lowest list price globally. Shows how incorporation can resolve judicialization -- prior to this, families had to sue.</div>
</div>
<div class="story" data-theme="budget_pressure">
  <div class="story-meta">
    <span class="date">2025-04</span>
    <span class="outlet">Conjur</span>
    <span class="theme">Budget Pressure</span>
  </div>
  <h3><a href="https://www.conjur.com.br/2025-abr-17/tj-rj-recebeu-35-acoes-relacionadas-a-saude-por-dia-nos-ultimos-quatro-anos/" target="_blank" rel="noopener">TJ-RJ recebeu 35 acoes sobre saude por dia nos ultimos 4 anos</a></h3>
  <div class="summary">TJRJ registered 53,157 health lawsuits between 2021-2025 -- 35 new cases per day. State government (55.4%) and Rio municipality (22.4%) together accounted for 78% of all health lawsuits.</div>
</div>
<div class="story" data-theme="defensoria_access">
  <div class="story-meta">
    <span class="date">2025-02-21</span>
    <span class="outlet">Conjur</span>
    <span class="theme">Defensoria Access</span>
  </div>
  <h3><a href="https://www.conjur.com.br/2025-fev-21/41-das-comarcas-estaduais-e-60-das-subsecoes-federais-nao-tem-defensor-publico/" target="_blank" rel="noopener">Brasil esta longe de colocar Defensoria em todas as comarcas</a></h3>
  <div class="summary">Despite Constitutional Amendment 80/2014 deadline, 41% of state comarcas and 60% of federal subsections still lacked public defenders as of June 2024. Coverage rose from 47% to 59.1% between 2021 and 2024 -- still far from universal.</div>
</div>
<div class="story" data-theme="municipal_adaptation">
  <div class="story-meta">
    <span class="date">2025-02</span>
    <span class="outlet">Campo Grande News</span>
    <span class="theme">Municipal Adaptation</span>
  </div>
  <h3><a href="https://www.campograndenews.com.br/brasil/cidades/avalanche-de-acoes-judiciais-na-saude-so-cresce-e-desorganiza-orcamento-em-ms" target="_blank" rel="noopener">Avalanche de acoes judiciais na saude so cresce e desorganiza orcamento em MS</a></h3>
  <div class="summary">MS health lawsuits rose from 6,500 (2023) to 7,659 (2024), with 810 new actions by Feb 2025 alone. State prosecutor described it as 'seizure' of public resources. Makes planned health policy execution impossible.</div>
</div>
<div class="story" data-theme="admin_failure">
  <div class="story-meta">
    <span class="date">2025-01</span>
    <span class="outlet">Folha de S.Paulo</span>
    <span class="theme">Admin Failure</span>
  </div>
  <h3><a href="https://www.sbmdn.org.br/sus-nao-entrega-ao-menos-76-medicamentos-e-procedimentos-incorporados-a-rede-publica-desde-2018/" target="_blank" rel="noopener">SUS nao entrega ao menos 76 medicamentos e procedimentos incorporados a rede publica desde 2018</a></h3>
  <div class="summary">76 of 242 CONITEC-incorporated items (31.4%) unavailable after average 648 days -- three times the legal deadline. Insulin analog incorporated 2019 unavailable after 2000+ days. Reasons: unsigned contracts missing protocols pending CIT. Baby Manuella (Acre) died before treatment available.</div>
</div>
<div class="story" data-theme="budget_pressure">
  <div class="story-meta">
    <span class="date">2025</span>
    <span class="outlet">Medicina S/A</span>
    <span class="theme">Budget Pressure</span>
  </div>
  <h3><a href="https://medicinasa.com.br/judicializacao-custos/" target="_blank" rel="noopener">Judicializacao da saude custou R$ 9,6 bilhoes a Uniao entre 2020 e 2024</a></h3>
  <div class="summary">Cumulative federal cost of health judicialization between 2020 and 2024 reached R$9.6 billion from 23,046 lawsuits. In 2024 alone, R$2.7 billion -- the highest on record. Eculizumab alone: R$1.77 billion across 2,871 cases.</div>
</div>
<div class="story" data-theme="budget_pressure">
  <div class="story-meta">
    <span class="date">2025</span>
    <span class="outlet">Correio do Estado</span>
    <span class="theme">Budget Pressure</span>
  </div>
  <h3><a href="https://correiodoestado.com.br/cidades/ms-e-vice-campeao-brasileiro-de-judicializacao-da-saude/460437/" target="_blank" rel="noopener">MS e vice-campeao brasileiro de judicializacao da Saude</a></h3>
  <div class="summary">Mato Grosso do Sul is second-highest state for per-capita health lawsuits (behind Federal District). Over 18,500 lawsuits in 2025. During 70-day period, 435 judicialization requests (~6/day).</div>
</div>
<div class="story" data-theme="crowd_out">
  <div class="story-meta">
    <span class="date">2025</span>
    <span class="outlet">SES Minas Gerais</span>
    <span class="theme">Crowd-Out</span>
  </div>
  <h3><a href="https://www.saude.mg.gov.br/judicializacao/" target="_blank" rel="noopener">Judicializacao da Saude (institutional page)</a></h3>
  <div class="summary">Minas Gerais Health Department: health judicialization consumes ~11% of state health budget. States that when someone sues for specific treatment, resources meant for collective end up going to single case.</div>
</div>
<div class="story" data-theme="pharma_industry">
  <div class="story-meta">
    <span class="date">2025</span>
    <span class="outlet">Revista Pesquisa FAPESP</span>
    <span class="theme">Pharma Industry</span>
  </div>
  <h3><a href="https://revistapesquisa.fapesp.br/en/growing-demands/" target="_blank" rel="noopener">Growing demands (Demandas crescentes)</a></h3>
  <div class="summary">92% increase in judicial proceedings for medicines over five years. SP state spent R$40 million in 2006-2007 on seven anticancer drugs via court orders, with R$7 million lacking clinical evidence of benefit.</div>
</div>
<div class="story" data-theme="individual_cases">
  <div class="story-meta">
    <span class="date">2025</span>
    <span class="outlet">CNN Brasil</span>
    <span class="theme">Individual Cases</span>
  </div>
  <h3><a href="https://www.cnnbrasil.com.br/nacional/menino-que-utilizava-remedio-mais-caro-do-mundo-para-tratar-doenca-rara-morre-aos-5-anos/" target="_blank" rel="noopener">Menino que utilizava remedio mais caro do mundo para tratar doenca rara morre aos 5 anos</a></h3>
  <div class="summary">Guilherme Martini died at age 5 despite receiving Zolgensma (R$12 million) through judicial action in 2021. Illustrates both successes and limitations of judicial access to high-cost treatments.</div>
</div>
<div class="story" data-theme="individual_cases">
  <div class="story-meta">
    <span class="date">2025</span>
    <span class="outlet">Metropoles</span>
    <span class="theme">Individual Cases</span>
  </div>
  <h3><a href="https://www.metropoles.com/distrito-federal/jovem-com-doenca-rara-e-fatal-nao-recebe-medicacao-ha-sete-meses" target="_blank" rel="noopener">Jovem com doenca rara e fatal nao recebe medicacao ha sete meses</a></h3>
  <div class="summary">17-year-old Davi with atypical hemolytic uremic syndrome had court order since 2017 guaranteeing eculizumab. Medication undelivered for 7 months due to bureaucratic transfer issues.</div>
</div>
<div class="story" data-theme="individual_cases">
  <div class="story-meta">
    <span class="date">2025</span>
    <span class="outlet">Instituto Oncoguia</span>
    <span class="theme">Individual Cases</span>
  </div>
  <h3><a href="https://www.oncoguia.org.br/conteudo/cancer-pacientes-vao-a-justica-por-acesso-a-tratamentos-sem-oferta-no-sus/16589/7/" target="_blank" rel="noopener">Cancer: pacientes vao a Justica por acesso a tratamentos sem oferta no SUS</a></h3>
  <div class="summary">Cintia (47) with advanced breast cancer obtained palbociclib (R$10,000/box) via court. After 9 months regained ability to perform activities she hadn't done in four years.</div>
</div>
<div class="story" data-theme="individual_cases">
  <div class="story-meta">
    <span class="date">2025</span>
    <span class="outlet">Olhar Juridico</span>
    <span class="theme">Individual Cases</span>
  </div>
  <h3><a href="https://www.olharjuridico.com.br/noticias/exibir.asp?id=46819" target="_blank" rel="noopener">Paciente com doenca autoimune rara consegue na Justica medicamento de R$ 14 mil a caixa</a></h3>
  <div class="summary">Patient with Erdheim-Chester Disease (~500 cases worldwide since 1930) obtained Vemurafenib (R$14,555/box, 4 boxes/month) through Defensoria Publica. Filed same day daughter sought help.</div>
</div>
<div class="story" data-theme="political_economy">
  <div class="story-meta">
    <span class="date">2025</span>
    <span class="outlet">Abrale</span>
    <span class="theme">Political Economy</span>
  </div>
  <h3><a href="https://abrale.org.br/abrale-na-midia/apos-decisao-do-stf-sobre-judicializacao-instituicoes-se-mobilizam-em-busca-de-dialogo-mais-profundo/" target="_blank" rel="noopener">Apos decisao do STF sobre judicializacao, instituicoes se mobilizam em busca de dialogo mais profundo</a></h3>
  <div class="summary">After STF Tema 1234 decision, patient associations (Abrale, Abrasta, Febrararas) mobilized politically, requesting CNJ meetings and seeking Congressional alternatives. Associations act as organized political players.</div>
</div>
<div class="story" data-theme="admin_failure">
  <div class="story-meta">
    <span class="date">2025</span>
    <span class="outlet">Folha de S.Paulo / SciELO</span>
    <span class="theme">Admin Failure</span>
  </div>
  <h3><a href="https://www.scielo.br/j/csp/a/SQNxybJVbkLFLRbNwmvMTdd/?lang=pt" target="_blank" rel="noopener">SUS waiting lists: 1.6 million Brazilians await surgery</a></h3>
  <div class="summary">1.6 million Brazilians on SUS surgical waiting lists. 5% die per year of waiting. Patients waiting 7 years have 18% higher mortality than those operated immediately. UK comparison: no one waits >18 weeks, 90% operated within that period.</div>
</div>
<div class="story" data-theme="procurement_cost">
  <div class="story-meta">
    <span class="date">2025</span>
    <span class="outlet">Futuro da Saude</span>
    <span class="theme">Procurement Cost</span>
  </div>
  <h3><a href="https://futurodasaude.com.br/medicamentos-nao-incorporados-no-sus-judicializacao/" target="_blank" rel="noopener">Medicamentos nao incorporados mais judicializados no SUS sao para doencas raras</a></h3>
  <div class="summary">Top non-incorporated judicially mandated drugs: vosoritida (achondroplasia) R$875M and atalureno (Duchenne) R$765M between 2022-2024. Pharma companies delay incorporation requests while litigation forces purchase at full price. BioMarin only planning Conitec submission for 2025.</div>
</div>
<div class="story" data-theme="procurement_cost">
  <div class="story-meta">
    <span class="date">2025</span>
    <span class="outlet">AGE-MG</span>
    <span class="theme">Procurement Cost</span>
  </div>
  <h3><a href="https://advocaciageral.mg.gov.br/justica-acolhe-pedido-da-age-mg-e-determina-bloqueio-de-r-21-milhoes-de-empresas-que-superfaturaram-compra-de-remedios-para-a-populacao/" target="_blank" rel="noopener">Justica acolhe pedido da AGE-MG e determina bloqueio por superfaturamento de Trikafta</a></h3>
  <div class="summary">Two importers overcharged ~R$2M for Trikafta (cystic fibrosis). Court froze R$5.3M and pierced corporate veil. Companies sold without ANVISA authorization. Market price ~R$650k vs prices charged far above.</div>
</div>
<div class="story" data-theme="institutional_response">
  <div class="story-meta">
    <span class="date">2025</span>
    <span class="outlet">Futuro da Saude</span>
    <span class="theme">Institutional Response</span>
  </div>
  <h3><a href="https://futurodasaude.com.br/judicializacao-decisao-do-stf/" target="_blank" rel="noopener">Apos decisao do STF 19.8% tiveram tratamentos interrompidos</a></h3>
  <div class="summary">Interfarma survey post-STF Tema 1234: 53.8% of patients continued treatment; 26.3% supply denied uncertain or pending; 19.8% had judicially-ordered treatments interrupted. Rare disease lawsuits grew 21.3% between 2022-2024 despite reforms.</div>
</div>
<div class="story" data-theme="budget_pressure">
  <div class="story-meta">
    <span class="date">2024-12</span>
    <span class="outlet">Ministerio da Saude</span>
    <span class="theme">Budget Pressure</span>
  </div>
  <h3><a href="https://www.gov.br/saude/pt-br/assuntos/noticias/2024/dezembro/pactuada-portaria-sobre-o-ressarcimento-de-medicamentos-judicializados" target="_blank" rel="noopener">Pactuada portaria sobre o ressarcimento de medicamentos judicializados</a></h3>
  <div class="summary">CIT approved historic portaria for inter-federative reimbursement of court-ordered ANVISA-registered medications. Ministry to begin payments January 2025, acknowledging unsustainable cost burden on subnational governments.</div>
</div>
<div class="story" data-theme="equity">
  <div class="story-meta">
    <span class="date">2024-12</span>
    <span class="outlet">Migalhas</span>
    <span class="theme">Equity</span>
  </div>
  <h3><a href="https://www.migalhas.com.br/depeso/444202/5-fatos-surpreendentes-sobre-a-judicializacao-da-saude-no-brasil" target="_blank" rel="noopener">5 fatos surpreendentes sobre a judicializacao da saude no Brasil</a></h3>
  <div class="summary">Reports 'paradoxical inequality': judicialization may deepen inequalities as those with more resources access justice more easily. Massive regional heterogeneity. Collective actions underutilized but yield 7% higher success.</div>
</div>
<div class="story" data-theme="institutional_response">
  <div class="story-meta">
    <span class="date">2024-11-21</span>
    <span class="outlet">Portal CNJ</span>
    <span class="theme">Institutional Response</span>
  </div>
  <h3><a href="https://www.cnj.jus.br/cnj-e-ans-assinam-acordo-para-reducao-da-judicializacao-da-saude-suplementar/" target="_blank" rel="noopener">CNJ e ANS assinam acordo para reducao da judicializacao da saude suplementar</a></h3>
  <div class="summary">Cooperation agreement to prevent new supplementary health lawsuits, speed case processing, provide technical-scientific support. Over 330,000 active lawsuits involve health plan operators.</div>
</div>
<div class="story" data-theme="budget_pressure">
  <div class="story-meta">
    <span class="date">2024-11</span>
    <span class="outlet">Revista Piaui</span>
    <span class="theme">Budget Pressure</span>
  </div>
  <h3><a href="https://piaui.folha.uol.com.br/materia/o-complexo-parte-ii_o-dinheiro-sempre/" target="_blank" rel="noopener">O Complexo: Parte II -- O dinheiro sempre</a></h3>
  <div class="summary">Investigative dossier on SUS underfunding. Ministry analysis: R$77B federal funding gap. Federal share fell from 45.3% (2012) to 37.6% (2022). EC 95/2016 spending ceiling cost SUS ~R$76B (2018-2022). Previne Brasil disrupted primary care. Tax subsidies to private health sector: R$70.7B.</div>
</div>
<div class="story" data-theme="budget_pressure">
  <div class="story-meta">
    <span class="date">2024-10-17</span>
    <span class="outlet">Agencia Brasil</span>
    <span class="theme">Budget Pressure</span>
  </div>
  <h3><a href="https://agenciabrasil.ebc.com.br/justica/noticia/2024-10/stf-finaliza-acordo-sobre-judicializacao-de-remedios-de-alto-custo" target="_blank" rel="noopener">STF finaliza acordo sobre judicializacao de remedios de alto custo</a></h3>
  <div class="summary">STF finalized agreement with federal/state/municipal governments on high-cost medication lawsuits. Monthly health lawsuits rose from 21,000 in 2020 to 61,000 in 2024, totaling ~600,000 annually.</div>
</div>
<div class="story" data-theme="institutional_response">
  <div class="story-meta">
    <span class="date">2024-10-08</span>
    <span class="outlet">Portal CNJ</span>
    <span class="theme">Institutional Response</span>
  </div>
  <h3><a href="https://www.cnj.jus.br/bases-de-dados-tecnicos-de-saude-devem-ser-integradas-no-e-natjus-4-0/" target="_blank" rel="noopener">Bases de dados tecnicos de saude devem ser integradas ao e-NatJus 4.0</a></h3>
  <div class="summary">e-NatJus 4.0: ~240,000 technical notes supporting 183,000 health cases. Consolidating multiple health databases into single platform for evidence-based judicial decisions.</div>
</div>
<div class="story" data-theme="institutional_response">
  <div class="story-meta">
    <span class="date">2024-10</span>
    <span class="outlet">Ministerio da Saude</span>
    <span class="theme">Institutional Response</span>
  </div>
  <h3><a href="https://www.gov.br/saude/pt-br/assuntos/noticias/2024/outubro/decisao-do-stf-sobre-concessao-de-medicamentos-fortalece-a-ciencia-e-reforca-o-papel-coletivo-do-sus" target="_blank" rel="noopener">Decisao do STF sobre concessao de medicamentos fortalece a ciencia e reforca o papel coletivo do SUS</a></h3>
  <div class="summary">Ministry created dedicated judicialization department and national platform. CONITEC brought into Fonajus. Minister Nisia called decision 'a milestone for Brazil and for SUS.'</div>
</div>
<div class="story" data-theme="political_economy">
  <div class="story-meta">
    <span class="date">2024-10</span>
    <span class="outlet">Ministerio da Saude</span>
    <span class="theme">Political Economy</span>
  </div>
  <h3><a href="https://www.gov.br/saude/pt-br/assuntos/noticias/2024/outubro/judicializacao-no-stf-ministra-nisia-afirma-esse-e-um-marco-para-o-brasil-e-para-o-sus" target="_blank" rel="noopener">Judicializacao: no STF ministra Nisia afirma: 'esse e um marco para o Brasil e para o SUS'</a></h3>
  <div class="summary">Health Minister celebrated STF Tema 1234 as victory for executive branch regaining control over pharmaceutical policy. Medicines approved by Anvisa but not in SUS can only be ordered under strict conditions.</div>
</div>
<div class="story" data-theme="institutional_response">
  <div class="story-meta">
    <span class="date">2024-09-20</span>
    <span class="outlet">STF Noticias</span>
    <span class="theme">Institutional Response</span>
  </div>
  <h3><a href="https://noticias.stf.jus.br/postsnoticias/stf-define-criterios-para-a-concessao-judicial-de-medicamentos-nao-incorporado-ao-sus/" target="_blank" rel="noopener">STF define criterios para a concessao judicial de medicamentos nao incorporados ao SUS</a></h3>
  <div class="summary">Landmark Tema 1234 judgment: courts generally cannot order non-CONITEC medications. Six cumulative conditions required. Judges must consult NAT-Jus, cannot rely solely on prescriptions.</div>
</div>
<div class="story" data-theme="institutional_response">
  <div class="story-meta">
    <span class="date">2024-09</span>
    <span class="outlet">Futuro da Saude</span>
    <span class="theme">Institutional Response</span>
  </div>
  <h3><a href="https://futurodasaude.com.br/decisao-stf-judicializacao-medicamentos/" target="_blank" rel="noopener">Decisao do STF pode organizar judicializacao sobre acesso a medicamentos mas fortalecimento da Conitec e criticado</a></h3>
  <div class="summary">STF decision may organize judicialization but patient associations and pharma criticize 'undisputed power' given to CONITEC. Concerns about transparency and Ministry influence on evaluations.</div>
</div>
<div class="story" data-theme="institutional_response">
  <div class="story-meta">
    <span class="date">2024-09</span>
    <span class="outlet">TJAM</span>
    <span class="theme">Institutional Response</span>
  </div>
  <h3><a href="https://www.tjam.jus.br/index.php/menu/sala-de-imprensa/12511-camara-de-resolucao-extrajudicial-de-litigios-de-saude-completa-seu-primeiro-ano-de-atividades-e-registra-89-7-das-demandas-resolvidas-no-periodo" target="_blank" rel="noopener">Camara de Resolucao Extrajudicial de Litigios de Saude completa primeiro ano</a></h3>
  <div class="summary">Amazonas extrajudicial chamber resolved 89.7% of demands without litigation in first year, saving R$1.78 million.</div>
</div>
<div class="story" data-theme="individual_cases">
  <div class="story-meta">
    <span class="date">2024-08</span>
    <span class="outlet">Metropoles / CNN Brasil</span>
    <span class="theme">Individual Cases</span>
  </div>
  <h3><a href="https://www.metropoles.com/saude/caso-enrico-remedio-terapia-duchenne" target="_blank" rel="noopener">Caso Enrico: como age remedio que custa R$ 17 milhoes</a></h3>
  <div class="summary">5-year-old Enrico needed Elevidys (R$17 million) for Duchenne muscular dystrophy. STF Minister Gilmar Mendes initially suspended 11 orders (total R$252 million). Agreement eventually reached between Union and Roche.</div>
</div>
<div class="story" data-theme="institutional_response">
  <div class="story-meta">
    <span class="date">2024-07-12</span>
    <span class="outlet">Portal CNJ</span>
    <span class="theme">Institutional Response</span>
  </div>
  <h3><a href="https://www.cnj.jus.br/tribunal-do-para-instala-em-belem-cejusc-especializado-em-saude/" target="_blank" rel="noopener">Tribunal do Para instala em Belem CEJUSC especializado em saude</a></h3>
  <div class="summary">TJPA established specialized health CEJUSC in Belem with statewide competence. First conciliation session resolved ICU bed/surgery case.</div>
</div>
<div class="story" data-theme="crowd_out">
  <div class="story-meta">
    <span class="date">2024-07-07</span>
    <span class="outlet">Conjur</span>
    <span class="theme">Crowd-Out</span>
  </div>
  <h3><a href="https://www.conjur.com.br/2024-jul-07/labirintos-da-judicializacao-da-saude/" target="_blank" rel="noopener">Labirintos da judicializacao da saude</a></h3>
  <div class="summary">Analysis: individualized technology-driven model of judicial healthcare undermines constitutional priority of prevention, primary care, and health surveillance. Favors individual demands at expense of structural policies.</div>
</div>
<div class="story" data-theme="institutional_response">
  <div class="story-meta">
    <span class="date">2024-04-02</span>
    <span class="outlet">Portal CNJ</span>
    <span class="theme">Institutional Response</span>
  </div>
  <h3><a href="https://www.cnj.jus.br/forum-do-judiciario-para-a-saude-aprova-medidas-para-reducao-da-judicializacao/" target="_blank" rel="noopener">Forum do Judiciario para a Saude aprova medidas para reducao da judicializacao</a></h3>
  <div class="summary">Under Minister Barroso, Fonajus approved working group for e-NatJus improvement, itinerant Fonajus to visit courts, 120-day deadline for state health committees to develop plans.</div>
</div>
<div class="story" data-theme="individual_cases">
  <div class="story-meta">
    <span class="date">2024-01</span>
    <span class="outlet">TJAC</span>
    <span class="theme">Individual Cases</span>
  </div>
  <h3><a href="https://www.tjac.jus.br/2024/01/paciente-consegue-na-justica-fornecimento-de-medicamento-nao-disponivel-no-sus/" target="_blank" rel="noopener">Paciente consegue na Justica fornecimento de medicamento nao disponivel no SUS</a></h3>
  <div class="summary">Patient with severe eosinophilic asthma facing risk of death obtained medication via court. State argued drug not on essential medicines list. Judge ordered supply within 5 days, R$1,000/day fine.</div>
</div>
<div class="story" data-theme="budget_pressure">
  <div class="story-meta">
    <span class="date">2024</span>
    <span class="outlet">The Conversation / Metropoles</span>
    <span class="theme">Budget Pressure</span>
  </div>
  <h3><a href="https://theconversation.com/judicializacao-consumiu-de-30-a-100-da-verba-da-saude-em-mais-de-250-cidades-brasileiras-230387" target="_blank" rel="noopener">Judicializacao consumiu de 30% a 100% da verba da saude em mais de 250 cidades brasileiras</a></h3>
  <div class="summary">Using DATAJUD data: in 2020, ~270 municipalities spent 30-100% of entire health budgets on judicialized demands. Nearly half of all 5,569 municipalities allocated up to 10% of health budget to judicial compliance.</div>
</div>
<div class="story" data-theme="budget_pressure">
  <div class="story-meta">
    <span class="date">2024</span>
    <span class="outlet">Jornal da Unicamp</span>
    <span class="theme">Budget Pressure</span>
  </div>
  <h3><a href="https://jornal.unicamp.br/edicao/721/judicializacao-de-medicamentos-poe-em-risco-sistema-publico-de-saude/" target="_blank" rel="noopener">Judicializacao de medicamentos poe em risco sistema publico de saude</a></h3>
  <div class="summary">Campinas spent R$47.7 million on court-ordered pharma assistance (2017-2021). 76% involved items absent from SUS lists, 23.7% were state/federal responsibility. Concluded judicialization risks sustainability of municipal health system.</div>
</div>
<div class="story" data-theme="institutional_response">
  <div class="story-meta">
    <span class="date">2024</span>
    <span class="outlet">TJCE</span>
    <span class="theme">Institutional Response</span>
  </div>
  <h3><a href="https://www.tjce.jus.br/noticias/9a-e-15a-varas-da-fazenda-publica-de-fortaleza-serao-exclusivas-para-demandas-de-saude/" target="_blank" rel="noopener">9a e 15a Varas da Fazenda Publica de Fortaleza serao exclusivas para demandas de saude</a></h3>
  <div class="summary">Ceara converted two courts to handle exclusively public health demands. ~2,500 pending cases to be distributed. Established Nucleo de Justica 4.0 for public health.</div>
</div>
<div class="story" data-theme="equity">
  <div class="story-meta">
    <span class="date">2024</span>
    <span class="outlet">APM / CFM / CNJ</span>
    <span class="theme">Equity</span>
  </div>
  <h3><a href="https://www.apm.org.br/infografico-apresenta-panoramas-da-judicializacao-da-saude-e-da-medicina-no-brasil/" target="_blank" rel="noopener">Infografico apresenta panoramas da Judicializacao da Saude e da Medicina no Brasil</a></h3>
  <div class="summary">Massive regional disparity: South has 5.11 cases per 1,000 inhabitants vs 0.80 in North. SP leads with 133,500 cases. Health litigation grew 198% over nine years while general litigation fell 6%.</div>
</div>
<div class="story" data-theme="enforcement">
  <div class="story-meta">
    <span class="date">2024</span>
    <span class="outlet">LEX Editora</span>
    <span class="theme">Enforcement</span>
  </div>
  <h3><a href="https://www.lex.com.br/justica-determina-bloqueio-de-verbas-para-fornecer-remedio-a-paciente-da-rede-publica-de-saude-com-cancer/" target="_blank" rel="noopener">Justica determina bloqueio de verbas para fornecer remedio a paciente com cancer</a></h3>
  <div class="summary">Judge in Caico (RN) blocked state funds to supply kidney cancer medication. Illustrates judges' power to sequester public budgets when states fail to provide court-ordered treatments.</div>
</div>
<div class="story" data-theme="procurement_cost">
  <div class="story-meta">
    <span class="date">2024</span>
    <span class="outlet">Portal TCU</span>
    <span class="theme">Procurement Cost</span>
  </div>
  <h3><a href="https://portal.tcu.gov.br/imprensa/noticias/tribunal-fiscaliza-a-gestao-de-demandas-judiciais-de-medicamento" target="_blank" rel="noopener">Tribunal fiscaliza gestao de demandas judiciais de medicamento</a></h3>
  <div class="summary">TCU audit found R$26.4 million in judicially purchased medicines expired between 2018-2022. Emergency procurement without competitive bidding leads to systematic waste. Highlights inefficiency of individualized judicial purchasing vs. centralized procurement.</div>
</div>
<div class="story" data-theme="municipal_adaptation">
  <div class="story-meta">
    <span class="date">2024</span>
    <span class="outlet">CGNoticias / Prefeitura Campo Grande</span>
    <span class="theme">Municipal Adaptation</span>
  </div>
  <h3><a href="https://www.campogrande.ms.gov.br/cgnoticias/noticia/impactos-no-orcamento-e-medidas-alternativas-a-judicializacao-sao-debatidas-durante-dialogo-deliberativo/" target="_blank" rel="noopener">Campo Grande cria Catjus e economiza R$ 425 mil em dois meses</a></h3>
  <div class="summary">Campo Grande spends ~R$26M/year on health judicialization. Created Catjus (Coordenacao de Apoio Tecnico a Judicializacao da Saude) which saved R$425k in Jul-Aug alone by redirecting patients to existing SUS services.</div>
</div>
<div class="story" data-theme="municipal_adaptation">
  <div class="story-meta">
    <span class="date">2024</span>
    <span class="outlet">Secretaria da Saude PR</span>
    <span class="theme">Municipal Adaptation</span>
  </div>
  <h3><a href="https://www.saude.pr.gov.br/Noticia/Experiencia-exitosa-do-Parana-para-diminuir-demandas-judiciais-de-medicamentos-e" target="_blank" rel="noopener">Experiencia exitosa do Parana para diminuir demandas judiciais de medicamentos</a></h3>
  <div class="summary">Parana spends R$300M/year on judicial health demands. Pioneered PREC pre-judicialization project and reimbursement mechanism: state buys Union-responsibility drugs, fixes price via Cemepar, obtains federal reimbursement. Recognized as national model.</div>
</div>
<div class="story" data-theme="judge_perspective">
  <div class="story-meta">
    <span class="date">2024</span>
    <span class="outlet">Migalhas</span>
    <span class="theme">Judge Perspective</span>
  </div>
  <h3><a href="https://www.migalhas.com.br/coluna/migalhas-de-direito-medico-e-bioetica/419202/judicializacao-da-saude-no-brasil-impacto-desafios-e-papel-do-natjus" target="_blank" rel="noopener">Judicializacao da saude no Brasil: Impacto desafios e papel do NatJus</a></h3>
  <div class="summary">NAT-Jus data from Roraima (2019-2024): only 12.3% of cases classified as urgent were genuinely urgent vs 66.5% non-urgent. Goias: 18.1% truly urgent vs 81.9% not. Many judges resist NAT-Jus consultation citing urgency judicial autonomy or missing infrastructure. 53.8% of NAT-Jus opinions fully favorable to patient.</div>
</div>
<div class="story" data-theme="budget_pressure">
  <div class="story-meta">
    <span class="date">2023-11</span>
    <span class="outlet">Ministerio da Saude</span>
    <span class="theme">Budget Pressure</span>
  </div>
  <h3><a href="https://www.gov.br/saude/pt-br/assuntos/noticias/2023/novembro/ministerio-da-saude-volta-a-ressarcir-estados-e-municipios-pela-judicializacao-de-medicamentos" target="_blank" rel="noopener">Ministerio da Saude volta a ressarcir estados e municipios pela judicializacao de medicamentos</a></h3>
  <div class="summary">Ministry of Health issued Portaria GM/MS No. 1,805 to resume reimbursing states and municipalities for judicialized medication purchases. Reimbursement had been suspended since 2017.</div>
</div>
<div class="story" data-theme="municipal_adaptation">
  <div class="story-meta">
    <span class="date">2023-11</span>
    <span class="outlet">Agencia Gov</span>
    <span class="theme">Municipal Adaptation</span>
  </div>
  <h3><a href="https://agenciagov.ebc.com.br/noticias/202311/ministerio-da-saude-volta-a-ressarcir-estados-e-municipios-pela-judicializacao-de-medicamentos" target="_blank" rel="noopener">Ministerio da Saude volta a ressarcir estados e municipios pela judicializacao de medicamentos</a></h3>
  <div class="summary">Federal reimbursement resumed after 6-year suspension (2017-2023). First states: SC, RS, PR, ES, MS, CE, PE. Dec 2024 CIT Portaria: Union reimburses 65% (80% for oncology), back-payments for 2018-2024 within 5 years.</div>
</div>
<div class="story" data-theme="budget_pressure">
  <div class="story-meta">
    <span class="date">2023-10</span>
    <span class="outlet">Folha de S.Paulo</span>
    <span class="theme">Budget Pressure</span>
  </div>
  <h3><a href="https://www.bioredbrasil.com.br/governo-federal-gasta-r-575-mi-na-compra-de-tres-remedios-para-doencas-raras-por-ordens-judiciais/" target="_blank" rel="noopener">Governo federal gasta R$ 575 mi na compra de tres remedios para doencas raras por ordens judiciais</a></h3>
  <div class="summary">Top 3 drugs = 53.25% of R$1.1B: Translarna R$257M Soliris R$216M Zolgensma R$101M. Total 2022: R$1.6B (up 335% from 2012). 50000+ active federal lawsuits. Zolgensma incorporated Dec 2022 but unavailable 9 months later.</div>
</div>
<div class="story" data-theme="enforcement">
  <div class="story-meta">
    <span class="date">2023-09-25</span>
    <span class="outlet">STF</span>
    <span class="theme">Enforcement</span>
  </div>
  <h3><a href="https://portal.stf.jus.br/" target="_blank" rel="noopener">STF nega sequestro de precatorios para doencas graves</a></h3>
  <div class="summary">STF limited sequestration of precatorios (court-ordered government debts) for health cases, even serious diseases. Balanced individual urgency against fiscal responsibility. Only allowed when no budgetary allocation exists.</div>
</div>
<div class="story" data-theme="individual_cases">
  <div class="story-meta">
    <span class="date">2023-09-05</span>
    <span class="outlet">Agencia Brasil</span>
    <span class="theme">Individual Cases</span>
  </div>
  <h3><a href="https://agenciabrasil.ebc.com.br/justica/noticia/2023-09/zanin-obriga-governo-fornecer-remedio-mais-caro-do-mundo-crianca" target="_blank" rel="noopener">Zanin obriga governo a fornecer remedio mais caro do mundo a crianca</a></h3>
  <div class="summary">STF Minister Zanin confirmed government must provide Zolgensma (~R$6 million) to 2-year-old, overturning STJ denial. Cited 'fundamental rights of the greatest magnitude -- rights to life and health of a child.'</div>
</div>
<div class="story" data-theme="procurement_cost">
  <div class="story-meta">
    <span class="date">2023-09</span>
    <span class="outlet">Metropoles</span>
    <span class="theme">Procurement Cost</span>
  </div>
  <h3><a href="https://www.metropoles.com/brasil/empresa-com-apenas-1-funcionario-leva-contrato-de-r-2858-mi-na-saude" target="_blank" rel="noopener">Empresa com apenas 1 funcionario leva contrato de R$ 285.8 mi na Saude</a></h3>
  <div class="summary">Auramedi Farmaceutica -- micro-enterprise with 1 employee and R$1.3M capital -- won R$285.8M contract without bidding for immunoglobulin. HQ found closed and without employees during business hours. Owner defendant in pandemic-era fraud case. Co-representative linked to Operacao Vampiro (2004).</div>
</div>
<div class="story" data-theme="pharma_industry">
  <div class="story-meta">
    <span class="date">2023-08-21</span>
    <span class="outlet">The Intercept Brasil</span>
    <span class="theme">Pharma Industry</span>
  </div>
  <h3><a href="https://www.intercept.com.br/2023/08/21/medicamentos-farmaceuticas-tentam-barrar-genericos-para-cancer-diabetes-hiv/" target="_blank" rel="noopener">Medicamentos: Farmaceuticas tentam barrar genericos para cancer</a></h3>
  <div class="summary">~50 lawsuits by foreign pharma companies to delay generic versions of ~50 medications for cancer, diabetes, HIV. Judicial strategy to extend patents and block cheaper generics.</div>
</div>
<div class="story" data-theme="equity">
  <div class="story-meta">
    <span class="date">2023-06</span>
    <span class="outlet">Agencia Brasil</span>
    <span class="theme">Equity</span>
  </div>
  <h3><a href="https://agenciabrasil.ebc.com.br/saude/noticia/2023-06/anemia-falciforme-foi-invisibilizada-pelo-racismo-apontam-entidades" target="_blank" rel="noopener">Anemia falciforme foi invisibilizada pelo racismo apontam entidades</a></h3>
  <div class="summary">~100000 patients with sickle cell disease in Brazil; 95% are Black. 30000+ preventable deaths annually. Most are Bolsa Familia beneficiaries. No SUS protocols until 2005 despite century of diagnosis. Ministry: institutional racism affects care quality for this population.</div>
</div>
<div class="story" data-theme="admin_failure">
  <div class="story-meta">
    <span class="date">2023-03</span>
    <span class="outlet">Folha de S.Paulo</span>
    <span class="theme">Admin Failure</span>
  </div>
  <h3><a href="https://agenciaaids.com.br/noticia/governo-bolsonaro-incinerou-medicamentos-de-alto-custo-para-doencas-raras-destaca-folha-de-s-paulo/" target="_blank" rel="noopener">Governo Bolsonaro incinerou medicamentos de alto custo para doencas raras</a></h3>
  <div class="summary">R$13.5M in rare disease drugs incinerated: Translarna R$2.74M eculizumab R$1.73M Spinraza R$319k. Total R$214.2M health products discarded since 2019. Stock data classified since 2018. Municipalities forced to buy via emergency procurement while federal stockpiles destroyed.</div>
</div>
<div class="story" data-theme="political_economy">
  <div class="story-meta">
    <span class="date">2023</span>
    <span class="outlet">SciELO / Revista de Saude Publica</span>
    <span class="theme">Political Economy</span>
  </div>
  <h3><a href="https://www.scielo.br/j/rsp/a/VJQ34GLNDB49xYVrGVKgDVF/" target="_blank" rel="noopener">Judicialization and right to health in Brazil: a trajectory of matches and mismatches</a></h3>
  <div class="summary">Comprehensive review of three-decade trajectory. Divide between pro-litigation camp (guaranteeing equitable rights) and anti-litigation camp (deepening inequalities). Ongoing political contest over legitimacy of judicial intervention.</div>
</div>
<div class="story" data-theme="institutional_response">
  <div class="story-meta">
    <span class="date">2022-11-14</span>
    <span class="outlet">Portal CNJ</span>
    <span class="theme">Institutional Response</span>
  </div>
  <h3><a href="https://www.cnj.jus.br/sistema-do-e-natjus-refina-busca-de-notas-e-pareceres-tecnicos-em-saude/" target="_blank" rel="noopener">Sistema do e-Natjus refina busca de notas e pareceres tecnicos em saude</a></h3>
  <div class="summary">CNJ improved e-NatJus search functionality. Platform had accumulated over 88,000 notes. Refinement aimed to support growing judicial demand for evidence-based health decisions.</div>
</div>
<div class="story" data-theme="conitec_politics">
  <div class="story-meta">
    <span class="date">2022-08-30</span>
    <span class="outlet">A Regra e Clara</span>
    <span class="theme">CONITEC Politics</span>
  </div>
  <h3><a href="https://aregraeclara.org.br/prazo-de-180-dias-nao-e-cumprido/" target="_blank" rel="noopener">Prazo de 180 dias para oferta de novos medicamentos via de regra nao e cumprido</a></h3>
  <div class="summary">CGU audit of 25 medications: zero met 180-day legal deadline. Average delay 624 days. Financing-definition stage alone ~300 days; gap from financing to first acquisition ~265 days. Maximum observed delay: 1314 days (3.6 years). Created Monitor dos 180 Dias tracking 900+ incorporation cases since 2012.</div>
</div>
<div class="story" data-theme="admin_failure">
  <div class="story-meta">
    <span class="date">2022-07</span>
    <span class="outlet">Agencia Brasil / Radioagencia</span>
    <span class="theme">Admin Failure</span>
  </div>
  <h3><a href="https://agenciabrasil.ebc.com.br/radioagencia-nacional/saude/audio/2022-07/falta-de-medicamentos-atinge-80-das-cidades-brasileiras" target="_blank" rel="noopener">Falta de medicamentos atinge 80% das cidades brasileiras</a></h3>
  <div class="summary">CNM survey of 3,360 municipalities: 80% reported medicine shortages. 68% lacked amoxicillin, 66% lacked dipirona. 1,392 municipalities resorted to emergency procurement. Ministry admitted low stock of ~90 substances including antibiotics, saline solution.</div>
</div>
<div class="story" data-theme="admin_failure">
  <div class="story-meta">
    <span class="date">2022-07</span>
    <span class="outlet">Revista Piaui</span>
    <span class="theme">Admin Failure</span>
  </div>
  <h3><a href="https://piaui.folha.uol.com.br/materia/farra-ilimitada/" target="_blank" rel="noopener">Farra ilimitada</a></h3>
  <div class="summary">Secret budget (orcamento secreto) fraud in SUS. Municipalities inflated procedure counts: 540k tooth extractions in city of 38k. Parliamentary kickbacks up to 30%. Maranhao attracted R$918M. SUS audits collapsed from 1300/year to 151. Baby Gael died -- hospital lacked pediatrician incubator neonatal ICU despite city receiving millions.</div>
</div>
<div class="story" data-theme="individual_cases">
  <div class="story-meta">
    <span class="date">2022</span>
    <span class="outlet">CNN Brasil</span>
    <span class="theme">Individual Cases</span>
  </div>
  <h3><a href="https://www.cnnbrasil.com.br/saude/familia-busca-ajuda-para-comprar-remedio-de-r-7-milhoes-a-bebe-com-doenca-rara/" target="_blank" rel="noopener">Familia busca ajuda para comprar remedio de R$ 7 milhoes a bebe com doenca rara</a></h3>
  <div class="summary">Henri with AME couldn't move legs/arms, had respiratory difficulties. Mother mobilized social media for R$7 million Zolgensma. He eventually received it -- 'O Henri renasceu.'</div>
</div>
<div class="story" data-theme="individual_cases">
  <div class="story-meta">
    <span class="date">2022</span>
    <span class="outlet">Jovem Pan</span>
    <span class="theme">Individual Cases</span>
  </div>
  <h3><a href="https://jovempan.com.br/noticias/brasil/menino-de-1-ano-morre-de-doenca-rara-e-familia-lamenta-demora-da-uniao-para-comprar-remedio-mais-caro-do-mundo.html" target="_blank" rel="noopener">Menino de 3 anos morre de doenca rara e familia lamenta demora do governo para comprar remedio</a></h3>
  <div class="summary">3-year-old Vinicius died from AME. Family blamed government delay in purchasing Zolgensma. Symbol of how bureaucratic delays fulfilling judicial orders can be fatal.</div>
</div>
<div class="story" data-theme="admin_failure">
  <div class="story-meta">
    <span class="date">2022</span>
    <span class="outlet">EPSJV / Fiocruz</span>
    <span class="theme">Admin Failure</span>
  </div>
  <h3><a href="https://www.epsjv.fiocruz.br/podcast/falta-de-medicamentos-atinge-mais-de-80-das-cidades" target="_blank" rel="noopener">Falta de medicamentos atinge mais de 80% das cidades</a></h3>
  <div class="summary">Fiocruz analysis: SUS medicine shortages are structural, not temporary. Brazil's domestic pharmaceutical ingredient production fell from 50% to 5% of needs over 40 years. 2017 financing reform reduced 6 blocks to 2, fragmenting the system.</div>
</div>
<div class="story" data-theme="procurement_cost">
  <div class="story-meta">
    <span class="date">2022</span>
    <span class="outlet">IDEC</span>
    <span class="theme">Procurement Cost</span>
  </div>
  <h3><a href="https://idec.org.br/release/remedio-de-r-65-milhoes-preco-baseado-na-cura-e-injusto-e-cruel-diz-idec" target="_blank" rel="noopener">Remedio de R$ 6,5 milhoes: preco baseado na cura e injusto e cruel</a></h3>
  <div class="summary">IDEC criticized CMED for raising Zolgensma from R$2.9M to R$6.5M using 'value-based pricing' (comparing to years of competitor Spinraza). Families forced to sue for access. Later resolved: SUS adopted risk-sharing agreement, achieving lowest global price.</div>
</div>
<div class="story" data-theme="municipal_adaptation">
  <div class="story-meta">
    <span class="date">2022</span>
    <span class="outlet">Prefeitura Vitoria da Conquista</span>
    <span class="theme">Municipal Adaptation</span>
  </div>
  <h3><a href="https://www.pmvc.ba.gov.br/camara-de-conciliacao-em-saude-amplia-atendimentos-para-dar-mais-rapidez-as-demandas-dos-usuarios/" target="_blank" rel="noopener">Camara de Conciliacao em Saude amplia atendimentos</a></h3>
  <div class="summary">Vitoria da Conquista created pioneering CCS in Bahia (March 2022) via Technical Cooperation Agreement between municipal health and Defensoria. Restructured 2023 to expand legal team to 2 days/week. Resolves medication/treatment requests without litigation.</div>
</div>
<div class="story" data-theme="conitec_politics">
  <div class="story-meta">
    <span class="date">2022</span>
    <span class="outlet">Cadernos de Saude Publica</span>
    <span class="theme">CONITEC Politics</span>
  </div>
  <h3><a href="https://www.scielo.br/j/csp/a/HDhFhXTLTVSh4j99Qqv5NpP/?lang=pt" target="_blank" rel="noopener">Pharmaceutical industry interference in CONITEC incorporation process (Tamachiro et al)</a></h3>
  <div class="summary">Study of 514 incorporation requests (2012-2020): 37% from pharma companies; industry provided 70.7% of all public consultation contributions. One submission (nusinersena) generated 41787 contributions. Companies deliberately avoid CONITEC when evidence is weak preferring judicialization. 52.7% of industry requests rejected.</div>
</div>
<div class="story" data-theme="individual_cases">
  <div class="story-meta">
    <span class="date">2021-11</span>
    <span class="outlet">IstoE Dinheiro</span>
    <span class="theme">Individual Cases</span>
  </div>
  <h3><a href="https://istoedinheiro.com.br/justica-autoriza-importacao-do-remedio-mais-caro-do-mundo-a-bebe-de-1-ano/" target="_blank" rel="noopener">Justica autoriza importacao do remedio mais caro do mundo a bebe de 1 ano</a></h3>
  <div class="summary">Court authorized Zolgensma import (R$12 million) for 1-year-old Isabel with AME. Emphasized Zolgensma's cost-benefit over Spinraza (single application vs lifelong doses).</div>
</div>
<div class="story" data-theme="individual_cases">
  <div class="story-meta">
    <span class="date">2021-09-20</span>
    <span class="outlet">Folha de Pernambuco</span>
    <span class="theme">Individual Cases</span>
  </div>
  <h3><a href="https://www.folhape.com.br/noticias/justica-determina-que-uniao-forneca-remedio-mais-caro-do-mundo-para/198286/" target="_blank" rel="noopener">Justica determina que Uniao forneca remedio mais caro do mundo para tratamento de bebe com AME</a></h3>
  <div class="summary">Federal judge ordered Union to provide Zolgensma (~R$12 million) to 4-month-old Benjamin diagnosed with AME. Family had started internet campaign 'Ame o Ben.'</div>
</div>
<div class="story" data-theme="individual_cases">
  <div class="story-meta">
    <span class="date">2021-08-24</span>
    <span class="outlet">JFSP</span>
    <span class="theme">Individual Cases</span>
  </div>
  <h3><a href="https://www.jfsp.jus.br/comunicacao-publica/indice-noticias/24/08/2021-justica-determina-o-fornecimento-de-medicamento-a-homem-com-doenca-degenerativa" target="_blank" rel="noopener">Justica determina o fornecimento de medicamento a homem com doenca degenerativa</a></h3>
  <div class="summary">Man with familial amyloidotic polyneuropathy obtained Inotersen after Tafamidis (SUS-provided) failed. R$5,000/day fine for non-compliance.</div>
</div>
<div class="story" data-theme="institutional_response">
  <div class="story-meta">
    <span class="date">2021-08-03</span>
    <span class="outlet">Portal CNJ</span>
    <span class="theme">Institutional Response</span>
  </div>
  <h3><a href="https://www.cnj.jus.br/nat-jus-sp-alcanca-marca-de-1-mil-notas-tecnicas-na-biblioteca-digital/" target="_blank" rel="noopener">NAT-Jus/SP alcanca marca de 1 mil notas tecnicas na biblioteca digital</a></h3>
  <div class="summary">SP NAT-Jus reached 1,000 technical notes milestone. Notes produced by health professionals to guide judges on clinical questions about medications, treatments, procedures.</div>
</div>
<div class="story" data-theme="pharma_industry">
  <div class="story-meta">
    <span class="date">2021-04-28</span>
    <span class="outlet">The Intercept Brasil</span>
    <span class="theme">Pharma Industry</span>
  </div>
  <h3><a href="https://www.intercept.com.br/2021/04/28/lobby-contra-quebra-de-patentes-pagou-jornais/" target="_blank" rel="noopener">Lobby contra quebra de patentes de medicamentos pagou R$ 1,5 milhao a jornais</a></h3>
  <div class="summary">Pharma lobby against breaking patents paid R$1.5 million to newspapers for sponsored content. Valor Economico article cost at least R$300,000 for double-page customized content.</div>
</div>
<div class="story" data-theme="budget_pressure">
  <div class="story-meta">
    <span class="date">2020-10-22</span>
    <span class="outlet">Conjur</span>
    <span class="theme">Budget Pressure</span>
  </div>
  <h3><a href="https://www.conjur.com.br/2020-out-22/decisao-judicial-nao-desequilibrar-orcamento-fux/" target="_blank" rel="noopener">Decisao judicial nao deve desequilibrar o orcamento, diz Fux</a></h3>
  <div class="summary">STF Chief Justice Fux relieved municipality of Santa Isabel (SP) from court order to supply eculizumab (~R$860,000/year). Argued solidarity interpretation has deepened inequalities and diverted resources from sanitation and vaccination.</div>
</div>
<div class="story" data-theme="individual_cases">
  <div class="story-meta">
    <span class="date">2020-09-26</span>
    <span class="outlet">IstoE</span>
    <span class="theme">Individual Cases</span>
  </div>
  <h3><a href="https://istoe.com.br/morre-bebe-com-doenca-rara-que-motivou-campanha-para-compra-de-remedio-mais-caro-do-mundo/" target="_blank" rel="noopener">Morre bebe com doenca rara que motivou campanha para compra de remedio mais caro do mundo</a></h3>
  <div class="summary">Baby Aysha died before Zolgensma could be obtained. Highlights life-or-death stakes of delays in accessing high-cost medications.</div>
</div>
<div class="story" data-theme="equity">
  <div class="story-meta">
    <span class="date">2020-06-18</span>
    <span class="outlet">Health and Human Rights Journal</span>
    <span class="theme">Equity</span>
  </div>
  <h3><a href="https://www.hhrjournal.org/2020/06/18/right-to-medicines-litigation-and-universal-health-coverage-institutional-determinants-of-the-judicialization-of-health-in-brazil/" target="_blank" rel="noopener">Right-to-Medicines Litigation and Universal Health Coverage: Institutional Determinants of the Judicialization of Health in Brazil</a></h3>
  <div class="summary">Presence of Public Defender's Office is a major determinant of whether judicialization occurs. Municipalities without public defenders -- typically poorer/remote -- see far less litigation.</div>
</div>
<div class="story" data-theme="judge_perspective">
  <div class="story-meta">
    <span class="date">2020-06-10</span>
    <span class="outlet">Portal CNJ</span>
    <span class="theme">Judge Perspective</span>
  </div>
  <h3><a href="https://www.cnj.jus.br/solucoes-construidas-pelo-cnj-buscam-reduzir-judicializacao-da-saude/" target="_blank" rel="noopener">Solucoes construidas pelo CNJ buscam reduzir judicializacao da saude</a></h3>
  <div class="summary">Judges describe core dilemma: 'We are deciding under pressure about a subject we do not master because we are not doctors.' Receive one-sided petitions with urgency requests must decide immediately. Documents decade of CNJ institutional responses including National Health Forum and NAT-Jus.</div>
</div>
<div class="story" data-theme="pharma_industry">
  <div class="story-meta">
    <span class="date">2020-03</span>
    <span class="outlet">Folha de S.Paulo</span>
    <span class="theme">Pharma Industry</span>
  </div>
  <h3><a href="https://www1.folha.uol.com.br/cotidiano/2020/03/um-unico-remedio-custou-ao-sus-r-244-bilhoes-em-11-anos-revela-estudo.shtml" target="_blank" rel="noopener">Um unico remedio custou ao SUS R$ 2.44 bilhoes em 11 anos revela estudo</a></h3>
  <div class="summary">Eculizumab cost SUS R$2.44B over 11 years. Single law firm filed ~70% of 514 federal actions; 73% originated in DF. Of 414 patients roughly half lacked confirmed diagnosis. Operacao Calice de Higia (2017): purchases fell 49.5%. Price dropped 35% after ANVISA registration.</div>
</div>
<div class="story" data-theme="municipal_adaptation">
  <div class="story-meta">
    <span class="date">2020</span>
    <span class="outlet">SciELO / Revista de Administracao Publica</span>
    <span class="theme">Municipal Adaptation</span>
  </div>
  <h3><a href="https://www.scielo.br/j/rap/a/5YcctKRJTVmQnp5mRHkBBcj/?format=html&lang=pt" target="_blank" rel="noopener">Os impactos da judicializacao da saude no municipio de Sao Paulo: gasto publico e organizacao federativa</a></h3>
  <div class="summary">SP DJES study: judicialization consumed 6% of municipal pharmaceutical budget and 10% of hospital supplies budget. 55% of judicial costs were for medicines that were responsibility of other government levels (state/Union). SP created dedicated department in 2020.</div>
</div>
<div class="story" data-theme="enforcement">
  <div class="story-meta">
    <span class="date">2019-12</span>
    <span class="outlet">Agencia Brasil</span>
    <span class="theme">Enforcement</span>
  </div>
  <h3><a href="https://agenciabrasil.ebc.com.br/justica/noticia/2019-12/justica-mantem-bloqueio-de-r-325-milhoes-da-prefeitura-do-rio" target="_blank" rel="noopener">Justica mantem bloqueio de R$ 325 milhoes da prefeitura do Rio</a></h3>
  <div class="summary">TRT-RJ froze R$325 million from Rio de Janeiro municipality accounts to pay 20,000+ outsourced health workers (community agents, pharmacists, nursing techs) with salaries unpaid since October 2019.</div>
</div>
<div class="story" data-theme="pharma_industry">
  <div class="story-meta">
    <span class="date">2019-08</span>
    <span class="outlet">Reporter Brasil</span>
    <span class="theme">Pharma Industry</span>
  </div>
  <h3><a href="https://reporterbrasil.org.br/2019/08/conheca-a-lei-que-vai-causar-prejuizo-bilionario-ao-ministerio-da-saude-e-ampliar-lucro-das-farmaceuticas/" target="_blank" rel="noopener">Conheca a lei que vai causar prejuizo bilionario ao Ministerio da Saude e ampliar lucro das farmaceuticas</a></h3>
  <div class="summary">Investigates Article 40 of Industrial Property Law (1997) guaranteeing minimum 10-year patent validity, causing billions in losses to Ministry while amplifying pharma profits. Interfarma and Caeme used judicial actions to maintain monopolies.</div>
</div>
<div class="story" data-theme="budget_pressure">
  <div class="story-meta">
    <span class="date">2019-03-18</span>
    <span class="outlet">Portal CNJ</span>
    <span class="theme">Budget Pressure</span>
  </div>
  <h3><a href="https://www.cnj.jus.br/demandas-judiciais-relativas-a-saude-crescem-130-em-dez-anos/" target="_blank" rel="noopener">Demandas judiciais relativas a saude crescem 130% em dez anos</a></h3>
  <div class="summary">CNJ/Insper study: health judicial demands grew 130% between 2008 and 2017 vs 50% for overall litigation. Identified 498,715 first-instance health proceedings across 17 state courts. Ministry spending grew 13-fold in seven years.</div>
</div>
<div class="story" data-theme="pharma_industry">
  <div class="story-meta">
    <span class="date">2019-02</span>
    <span class="outlet">Reporter Brasil</span>
    <span class="theme">Pharma Industry</span>
  </div>
  <h3><a href="https://reporterbrasil.org.br/2019/02/industria-farmaceutica-ganha-assento-e-amplia-lobby-no-novo-congresso/" target="_blank" rel="noopener">Com doacoes de R$ 13 mi, industria farmaceutica ganha assento e amplia lobby no novo Congresso</a></h3>
  <div class="summary">Pharma industry donated R$13 million to campaigns. In 2010/2014 when private financing was allowed: R$26 million and R$57 million to 1,404 candidates. Former Hypera director admitted transferring R$30 million to MDB politicians.</div>
</div>
<div class="story" data-theme="crowd_out">
  <div class="story-meta">
    <span class="date">2019</span>
    <span class="outlet">SciELO / Revista de Administracao Publica</span>
    <span class="theme">Crowd-Out</span>
  </div>
  <h3><a href="https://www.scielo.br/j/rap/a/5YcctKRJTVmQnp5mRHkBBcj/?format=html&lang=pt" target="_blank" rel="noopener">Os impactos da judicializacao da saude no municipio de Sao Paulo</a></h3>
  <div class="summary">In 2011, judicialization spending in Sao Paulo = 6% of pharma policy budget, 10% of medication/supplies budget. 55% went toward medications that were state/federal responsibility. Three impacts: unequal access, federative imbalance, budget unpredictability.</div>
</div>
<div class="story" data-theme="equity">
  <div class="story-meta">
    <span class="date">2019</span>
    <span class="outlet">UFMG</span>
    <span class="theme">Equity</span>
  </div>
  <h3><a href="https://ufmg.br/comunicacao/noticias/judicializacao-da-saude-reforca-desigualdade" target="_blank" rel="noopener">Judicializacao reforca desigualdade entre clientes de planos de saude</a></h3>
  <div class="summary">UFMG study: health plan clients who judicialize most frequently held individual plans, lived in wealthy areas, had broader provider networks. Judicializing more accessible to wealthier citizens.</div>
</div>
<div class="story" data-theme="equity">
  <div class="story-meta">
    <span class="date">2019</span>
    <span class="outlet">International Journal for Equity in Health</span>
    <span class="theme">Equity</span>
  </div>
  <h3><a href="https://equityhealthj.biomedcentral.com/articles/10.1186/s12939-019-0914-5" target="_blank" rel="noopener">(Un)Equitable distribution of health resources and the judicialization of healthcare: 10 years of experience in Brazil</a></h3>
  <div class="summary">10-year analysis finds 'contrary positive discrimination tendency -- in favor of advantaged groups.' Access to courts skewed toward people with comparatively better health conditions due to economic situation.</div>
</div>
<div class="story" data-theme="equity">
  <div class="story-meta">
    <span class="date">2019</span>
    <span class="outlet">International Journal for Equity in Health</span>
    <span class="theme">Equity</span>
  </div>
  <h3><a href="https://equityhealthj.biomedcentral.com/articles/10.1186/s12939-019-0961-y" target="_blank" rel="noopener">Is the judicialization of health care bad for equity? A scoping review</a></h3>
  <div class="summary">Scoping review: evidence on regressivity inconclusive. Some studies find majority of litigants are poor/older individuals. Others show concentration in developed areas and high-cost medicines. Calls for more rigorous methodology.</div>
</div>
<div class="story" data-theme="municipal_adaptation">
  <div class="story-meta">
    <span class="date">2019</span>
    <span class="outlet">NSC Total</span>
    <span class="theme">Municipal Adaptation</span>
  </div>
  <h3><a href="https://www.nsctotal.com.br/noticias/nucleo-diminui-judicializacoes-na-area-da-saude-em-joinville" target="_blank" rel="noopener">Nucleo diminui judicializacoes na area da saude em Joinville</a></h3>
  <div class="summary">Joinville NAT-Jus (est. 2016): peak judicial spending R$10.4M in 2016. New actions fell from 227 (2017) to 144 (2018) -- 36.6% decline. 20% of cases resolved via patient guidance, 35% resolved without litigation. Collective actions dropped from 13 to 1.</div>
</div>
<div class="story" data-theme="conitec_politics">
  <div class="story-meta">
    <span class="date">2019</span>
    <span class="outlet">Cadernos de Saude Publica</span>
    <span class="theme">CONITEC Politics</span>
  </div>
  <h3><a href="https://www.scielo.br/j/csp/a/Fv7D7nRF8DfRXFzCvW7KWbN/?lang=pt" target="_blank" rel="noopener">Critical analysis of nusinersena/Spinraza incorporation into SUS (Caetano et al)</a></h3>
  <div class="summary">CONITEC unanimously rejected nusinersena in Nov 2018. After Attorney General intervention second submission approved March 2019 with no new clinical evidence. Public consultation: 41787 contributions in 10 days (56% of all contributions across 123 favorable recommendations 2012-2019). Federal spending: ~R$118M for 496 units in 2018.</div>
</div>
<div class="story" data-theme="institutional_response">
  <div class="story-meta">
    <span class="date">2018-09-18</span>
    <span class="outlet">Portal CNJ</span>
    <span class="theme">Institutional Response</span>
  </div>
  <h3><a href="https://www.cnj.jus.br/judicializacao-da-saude-goiania-instala-duas-varas-especializadas/" target="_blank" rel="noopener">Judicializacao da saude: Goiania ganha duas varas especializadas</a></h3>
  <div class="summary">Goiania installed two courts dedicated to health litigation, part of national movement for specialized judicial units following CNJ Recommendation No. 43.</div>
</div>
<div class="story" data-theme="judge_perspective">
  <div class="story-meta">
    <span class="date">2018-08-15</span>
    <span class="outlet">ConJur</span>
    <span class="theme">Judge Perspective</span>
  </div>
  <h3><a href="https://www.conjur.com.br/2018-ago-15/judicializacao-saude-juizes-passam-ditar-politicas-publicas-setor/" target="_blank" rel="noopener">Com judicializacao da saude juizes passam a ditar politicas publicas do setor</a></h3>
  <div class="summary">Judge Galhardo created pre-litigation committee in Araraquara reducing health lawsuits 70% (Innovare Prize 2007). Desembargador Dip: 'How can we deny when state defenses are generic?' TJSP handled 40000+ health cases/year costing SP over R$1B.</div>
</div>
<div class="story" data-theme="crowd_out">
  <div class="story-meta">
    <span class="date">2018-05</span>
    <span class="outlet">Senado Noticias</span>
    <span class="theme">Crowd-Out</span>
  </div>
  <h3><a href="https://www12.senado.leg.br/noticias/especiais/especial-cidadania/pais-busca-solucoes-para-aumento-de-judicializacao-na-saude" target="_blank" rel="noopener">Pais busca solucoes para aumento de judicializacao na saude</a></h3>
  <div class="summary">Senate special report: 130% increase in health lawsuits 2008-2017, spending reaching R$1.6 billion in 2016. R$7 billion/year in judicial sentences means money displaced from other health actions.</div>
</div>
<div class="story" data-theme="pharma_industry">
  <div class="story-meta">
    <span class="date">2018-04-04</span>
    <span class="outlet">SciELO em Perspectiva: Humanas</span>
    <span class="theme">Pharma Industry</span>
  </div>
  <h3><a href="https://humanas.blog.scielo.org/blog/2018/04/04/a-judicializacao-da-saude-existem-interferencias-da-industria-farmaceutica-no-fenomeno/" target="_blank" rel="noopener">A judicializacao da Saude: existem interferencias da industria farmaceutica no fenomeno?</a></h3>
  <div class="summary">Academic research summary showing justice and medicine have been articulated to serve pharma interests. Patient associations are linked to industry. Strong pressure to introduce new medications via judicial demands.</div>
</div>
<div class="story" data-theme="procurement_cost">
  <div class="story-meta">
    <span class="date">2018-03</span>
    <span class="outlet">Ministerio da Saude</span>
    <span class="theme">Procurement Cost</span>
  </div>
  <h3><a href="https://www.gov.br/saude/pt-br/assuntos/noticias/2018/marco/liminar-aponta-afronta-a-concorrencia-em-compra-para-doencas-raras" target="_blank" rel="noopener">Liminar aponta 'afronta a concorrencia' em compra para doencas raras</a></h3>
  <div class="summary">Rare disease drug distribution monopoly: ANVISA resolution required manufacturer authorization for importers, creating single-distributor monopolies. Federal judge ruled this violated bidding competition principles. 2010-2015: R$2.7B spent judicially, 54% on just 3 drugs (Elaprase, Naglazyme, Soliris).</div>
</div>
<div class="story" data-theme="institutional_response">
  <div class="story-meta">
    <span class="date">2018-03</span>
    <span class="outlet">Folha de S.Paulo</span>
    <span class="theme">Institutional Response</span>
  </div>
  <h3><a href="https://www1.folha.uol.com.br/cotidiano/2018/03/pedidos-de-remedio-na-justica-caem-e-sp-evita-gastos-de-r-205-milhoes.shtml" target="_blank" rel="noopener">Pedidos de remedio na Justica caem e SP evita gastos de R$ 205 milhoes</a></h3>
  <div class="summary">First decline in a decade: SP judicial health spending from R$1.09B to R$887M (16% drop 27% for Defensoria cases). Acessa SUS pre-litigation program. 1 in 4 judicially ordered drugs already on SUS list. R$40M fraud scheme uncovered in 2015.</div>
</div>
<div class="story" data-theme="political_economy">
  <div class="story-meta">
    <span class="date">2018</span>
    <span class="outlet">Faculdade de Medicina UFMG</span>
    <span class="theme">Political Economy</span>
  </div>
  <h3><a href="https://www.medicina.ufmg.br/pesquisa-avalia-interferencia-da-industria-farmaceutica-na-judicializacao-da-saude/" target="_blank" rel="noopener">Pesquisa avalia interferencia da industria farmaceutica na judicializacao da saude</a></h3>
  <div class="summary">UFMG doctoral research: patients obtain high-cost treatments that aren't always best options but generate profit for lawyers, doctors, pharma. MG spent R$290 million on judicial health actions in 2016. Purpose of resolving public policy problem ended up favoring pharma profits.</div>
</div>
<div class="story" data-theme="equity">
  <div class="story-meta">
    <span class="date">2017-10</span>
    <span class="outlet">MPMS</span>
    <span class="theme">Equity</span>
  </div>
  <h3><a href="https://www.mpms.mp.br/noticias/2017/10/luta-pela-vida-reforco-da-desigualdade-ou-gasto-desenfreadoa-a-dificil-equacao-da-judicializacao-da-saude" target="_blank" rel="noopener">Luta pela vida, reforco da desigualdade ou gasto desenfreado?</a></h3>
  <div class="summary">SP 2010-2014: of 56,000 cases, 64% filed by private lawyers (only 13.8% public defenders), nearly half of prescriptions from private doctors. Success rates exceed 80% but procedural costs exclude poorest.</div>
</div>
<div class="story" data-theme="municipal_adaptation">
  <div class="story-meta">
    <span class="date">2017-08-30</span>
    <span class="outlet">Portal CNJ</span>
    <span class="theme">Municipal Adaptation</span>
  </div>
  <h3><a href="https://www.cnj.jus.br/camara-de-conciliacao-de-saude-resolve-80-dos-casos-na-bahia/" target="_blank" rel="noopener">Camara de Conciliacao de Saude resolve 80% dos casos na Bahia</a></h3>
  <div class="summary">Bahia's CCS achieved 80% resolution rate within 9 months of establishment. Brings together Defensoria and health secretariats to resolve medication/treatment requests without litigation. Jan-Jul 2024: 3,409 visits, 4,164 assessments.</div>
</div>
<div class="story" data-theme="budget_pressure">
  <div class="story-meta">
    <span class="date">2017-08-23</span>
    <span class="outlet">Portal TCU</span>
    <span class="theme">Budget Pressure</span>
  </div>
  <h3><a href="https://portal.tcu.gov.br/imprensa/noticias/aumentam-os-gastos-publicos-com-judicializacao-da-saude" target="_blank" rel="noopener">Aumentam os gastos publicos com judicializacao da saude</a></h3>
  <div class="summary">TCU audit: federal spending on health litigation grew from R$70 million in 2008 to R$1 billion in 2015 -- 1,300% increase. Medication supply accounts for 80% of cases. TCU found measures taken by Ministry and states were insufficient.</div>
</div>
<div class="story" data-theme="enforcement">
  <div class="story-meta">
    <span class="date">2017-05-08</span>
    <span class="outlet">STJ</span>
    <span class="theme">Enforcement</span>
  </div>
  <h3><a href="https://www.stj.jus.br/sites/portalp/Paginas/Comunicacao/Noticias-antigas/2017/2017-05-08_07-59_Fazenda-publica-pode-ser-multada-por-nao-fornecer-medicamento.aspx" target="_blank" rel="noopener">Fazenda publica pode ser multada por nao fornecer medicamento</a></h3>
  <div class="summary">STJ Tema 98: First Section unanimously ruled daily fines (astreintes) can be imposed on government for non-compliance with medication supply orders. RS case: glaucoma patient won half-minimum-wage daily fine.</div>
</div>
<div class="story" data-theme="pharma_industry">
  <div class="story-meta">
    <span class="date">2017-02</span>
    <span class="outlet">Folha de S.Paulo</span>
    <span class="theme">Pharma Industry</span>
  </div>
  <h3><a href="https://cqcs.com.br/noticia/mafia-da-judicializacao-da-saude/" target="_blank" rel="noopener">A mafia da judicializacao da saude</a></h3>
  <div class="summary">Op-ed by Pedro Ramos. Describes Operacao Mr. Hyde: unnecessary surgeries with low-quality materials. Fraud ranges from trivial items to expensive unregistered drugs. Organized networks of doctors lawyers and pharma representatives.</div>
</div>
<div class="story" data-theme="political_economy">
  <div class="story-meta">
    <span class="date">2016-11</span>
    <span class="outlet">Folha de S.Paulo</span>
    <span class="theme">Political Economy</span>
  </div>
  <h3><a href="https://www1.folha.uol.com.br/cotidiano/2016/11/nao-lido-com-o-cofre-diz-ministra-do-stf-sobre-judicializacao-da-saude.shtml" target="_blank" rel="noopener">Nao lido com o cofre diz ministra do STF sobre judicializacao da saude</a></h3>
  <div class="summary">STF President Carmen Lucia: 'I deal with the human not the treasury.' Health Minister Barros: 'judicial action displaces resources.' 80% of actions for one drug from single law firm. Hypercholesterolemia fraud: R$36M doctors paid R$300/prescription. NAT-Jus platform launched.</div>
</div>
<div class="story" data-theme="pharma_industry">
  <div class="story-meta">
    <span class="date">2016-10-16</span>
    <span class="outlet">Estadao</span>
    <span class="theme">Pharma Industry</span>
  </div>
  <h3><a href="https://noticias.uol.com.br/saude/ultimas-noticias/estado/2016/10/17/gasto-do-governo-com-remedio-sem-aval-da-anvisa-cresce-220-vezes-em-5-anos.htm" target="_blank" rel="noopener">Gasto do governo com remedio sem aval da Anvisa cresce 220 vezes em 5 anos</a></h3>
  <div class="summary">Non-ANVISA-registered drug spending grew 220x in 5 years: R$2.4M in 2010 (2% of R$122M total) to R$545M in 2015 (50% of R$1.1B total). Cancer drugs rare disease treatments hepatitis C and cannabidiol products drove growth. STF judging Tema 500 on obligation to provide non-registered drugs.</div>
</div>
<div class="story" data-theme="institutional_response">
  <div class="story-meta">
    <span class="date">2016-07</span>
    <span class="outlet">TRF4</span>
    <span class="theme">Institutional Response</span>
  </div>
  <h3><a href="https://www.trf4.jus.br/trf4/controlador.php?acao=noticia_visualizar&id_noticia=12050" target="_blank" rel="noopener">TRF4 implanta as primeiras varas federais do pais especializadas em saude</a></h3>
  <div class="summary">First federal courts specialized in health: 3rd Federal Court of Curitiba and four in Porto Alegre. Responded to CNJ Recommendation No. 43.</div>
</div>
<div class="story" data-theme="admin_failure">
  <div class="story-meta">
    <span class="date">2016-06</span>
    <span class="outlet">TJDFT</span>
    <span class="theme">Admin Failure</span>
  </div>
  <h3><a href="https://www.tjdft.jus.br/institucional/imprensa/noticias/2016/junho/espera-de-quase-10-anos-na-fila-de-cirurgia-gera-indenizacao-a-paciente-da-rede-publica-de-saude" target="_blank" rel="noopener">Espera de quase 10 anos na fila de cirurgia gera indenizacao a paciente da rede publica de saude</a></h3>
  <div class="summary">DF condemned to R$20k damages for child waiting nearly 10 years for cranial surgery that should be done in infancy. Court recognized state negligence via omission -- failing to provide care the SUS promises.</div>
</div>
<div class="story" data-theme="pharma_industry">
  <div class="story-meta">
    <span class="date">2015-12-07</span>
    <span class="outlet">Reporter Brasil</span>
    <span class="theme">Pharma Industry</span>
  </div>
  <h3><a href="https://reporterbrasil.org.br/2015/12/lobby-da-industria-farmaceutica-poe-direito-a-saude-na-uti/" target="_blank" rel="noopener">Lobby da industria farmaceutica poe direito a saude na UTI</a></h3>
  <div class="summary">Investigative piece: pharmaceutical industry invests heavily in lobby strategies. Between 2008 and 2015, real growth in medicine budget was 74%, but judicialization of medicines grew 1,006%.</div>
</div>
<div class="story" data-theme="pharma_industry">
  <div class="story-meta">
    <span class="date">2015-12</span>
    <span class="outlet">Reporter Brasil</span>
    <span class="theme">Pharma Industry</span>
  </div>
  <h3><a href="https://reporterbrasil.org.br/2015/12/a-polemica-receita-da-bancada-do-medicamento-no-congresso/" target="_blank" rel="noopener">A polemica receita da Bancada do Medicamento no Congresso</a></h3>
  <div class="summary">Exposes informal 'Bancada do Medicamento' -- eight parliamentarians defending pharma interests. Specific deputies received R$150,000 from Interfarma in 2010. Global pharma sector: ~US$1 trillion annual revenue.</div>
</div>
<div class="story" data-theme="pharma_industry">
  <div class="story-meta">
    <span class="date">2015-09-13</span>
    <span class="outlet">ALMG</span>
    <span class="theme">Pharma Industry</span>
  </div>
  <h3><a href="https://www.almg.gov.br/acompanhe/noticias/arquivos/2015/09/13_seminario_judicializacao_saude.html" target="_blank" rel="noopener">Especialistas criticam lobby de fabricantes de medicamentos</a></h3>
  <div class="summary">Seminar at MG Legislature: experts criticized pharma lobby leading to 'inadequate conduct by healthcare providers.' Evidence of coordinated action between prescribers, lawyers, and pharma.</div>
</div>
<div class="story" data-theme="procurement_cost">
  <div class="story-meta">
    <span class="date">2015-05-25</span>
    <span class="outlet">Estadao</span>
    <span class="theme">Procurement Cost</span>
  </div>
  <h3><a href="https://www2.senado.leg.br/bdsf/browse?type=author&value=Cambricoli%2C+Fabiana" target="_blank" rel="noopener">Governos gastam R$ 314 milhoes com remedio importado</a></h3>
  <div class="summary">R$314M spent on imported drugs from judicial decisions in 2014 forcing state and Union to purchase medications without ANVISA registration. Documents fiscal cost of judicially mandated imports.</div>
</div>
<div class="story" data-theme="defensoria_access">
  <div class="story-meta">
    <span class="date">2015</span>
    <span class="outlet">Cadernos de Saude Publica / SciELO</span>
    <span class="theme">Defensoria Access</span>
  </div>
  <h3><a href="https://scielosp.org/article/csp/2015.v31n3/451-462/" target="_blank" rel="noopener">Biehl et al: right to medicines litigation in Rio Grande do Sul</a></h3>
  <div class="summary">Princeton/Johns Hopkins study of 1,262 lawsuits in RS: presence of Defensoria associated with 7x increase in probability of municipality having medicine lawsuit. Demonstrates that access to legal representation -- not just disease burden -- drives litigation geography.</div>
</div>
<div class="story" data-theme="pharma_industry">
  <div class="story-meta">
    <span class="date">2014</span>
    <span class="outlet">SciELO / Revista de Saude Publica</span>
    <span class="theme">Pharma Industry</span>
  </div>
  <h3><a href="https://www.scielo.br/j/rsp/a/66MXhZ5GyBFwWYGLNKkX55P/?lang=pt" target="_blank" rel="noopener">Medicos, advogados e industria farmaceutica na judicializacao da saude em Minas Gerais</a></h3>
  <div class="summary">MG study (1999-2009): single doctor from one law office responsible for ~44% of prescriptions in 117 actions. Greater concentration for newer, more expensive medications. Pharma targets medical students/residents via philanthropy-disguised marketing.</div>
</div>
<div class="story" data-theme="equity">
  <div class="story-meta">
    <span class="date">2013-08-29</span>
    <span class="outlet">Health and Human Rights Journal</span>
    <span class="theme">Equity</span>
  </div>
  <h3><a href="https://www.hhrjournal.org/2013/08/29/the-right-to-health-in-the-courts-of-brazil-worsening-health-inequities/" target="_blank" rel="noopener">The right to health in the courts of Brazil: Worsening health inequities?</a></h3>
  <div class="summary">Examines whether judicial enforcement worsens health inequities. Growing proportion of cases from supplementary insurance (25% of population, wealthier) and small role of public defenders suggest regressive pattern.</div>
</div>
<div class="story" data-theme="defensoria_access">
  <div class="story-meta">
    <span class="date">2013-03</span>
    <span class="outlet">Conjur / IPEA</span>
    <span class="theme">Defensoria Access</span>
  </div>
  <h3><a href="https://www.conjur.com.br/2013-mar-12/mapa-defensoria-mostra-faltam-defensores-72-comarcas/" target="_blank" rel="noopener">Mapa da Defensoria mostra que faltam defensores em 72% das comarcas</a></h3>
  <div class="summary">IPEA/ANADEP 'Mapa da Defensoria': public defenders absent from 72% of 2,680 comarcas. Only 5,054 of 8,489 positions filled (59.5%). Deficit most severe in small districts (<100k pop) with lower HDI. Total deficit: 10,578 defenders.</div>
</div>
<div class="story" data-theme="pharma_industry">
  <div class="story-meta">
    <span class="date">2012</span>
    <span class="outlet">SciELO / Physis</span>
    <span class="theme">Pharma Industry</span>
  </div>
  <h3><a href="https://www.scielo.br/j/physis/a/fXmMTm8w6v5WhZHH3swzGFN/" target="_blank" rel="noopener">Ligacoes perigosas: industria farmaceutica, associacoes de pacientes e as batalhas judiciais por acesso a medicamentos</a></h3>
  <div class="summary">Documents 'dangerous liaisons' between pharma, patient associations, and judicial battles. Connections result from market expansion strategies. Lawsuits increased ~350% in RJ between 2001-2005.</div>
</div>
<div class="story" data-theme="defensoria_access">
  <div class="story-meta">
    <span class="date">2010-2014</span>
    <span class="outlet">SES-SP / Chieffi</span>
    <span class="theme">Defensoria Access</span>
  </div>
  <h3><a href="https://periodicos.saude.sp.gov.br/BEPA182/article/view/38466" target="_blank" rel="noopener">Advogados privados lideram 64% das acoes de saude em SP</a></h3>
  <div class="summary">Chieffi SP data 2010-2014: of 56,000 health lawsuits, private lawyers led 64%, Defensoria only 13.8%, prosecutors 9%. Of 20 most demanded drugs, only 4 lacked SUS alternatives. 63% increase in volume over period. 'Judicialization accentuates inequality in access.'</div>
</div>
<div class="story" data-theme="pharma_industry">
  <div class="story-meta">
    <span class="date">2010</span>
    <span class="outlet">SciELO / Revista de Saude Publica</span>
    <span class="theme">Pharma Industry</span>
  </div>
  <h3><a href="https://www.scielo.br/j/rsp/a/hcnPQzz9FLGGGxHbb78gzPy/?lang=pt" target="_blank" rel="noopener">Acoes judiciais: estrategia da industria farmaceutica para introducao de novos medicamentos</a></h3>
  <div class="summary">Landmark Chieffi & Barata study: 2,927 judicial actions in SP in 2006. Of 565 legal agents, 549 (97.2%) were private attorneys. 19 lawyers filed ~63% of all lawsuits; for some drugs, one lawyer filed 70% of actions.</div>
</div>
<div class="story" data-theme="pharma_industry">
  <div class="story-meta">
    <span class="date">2008-09-01</span>
    <span class="outlet">Governo do Estado de Sao Paulo</span>
    <span class="theme">Pharma Industry</span>
  </div>
  <h3><a href="https://www.saopaulo.sp.gov.br/ultimas-noticias/policia-prende-quadrilha-que-fraudou-r-63-milhoes-do-estado/" target="_blank" rel="noopener">Policia prende quadrilha que fraudou R$ 63 milhoes do Estado (Operacao Garra Rufa)</a></h3>
  <div class="summary">Criminal network of three pharma labs, an NGO, doctors, and lawyers defrauded R$63 million. Doctors issued improper reports, lawyers filed lawsuits, many patients didn't know suits were filed on their behalf.</div>
</div>
</div>
</main>

<footer>
  Generated by <code>bash build.sh site</code>
</footer>

<script>
var stories = document.querySelectorAll('.story');
var buttons = document.querySelectorAll('.filters button');
var countEl = document.getElementById('story-count');

function updateCount() {
  var visible = document.querySelectorAll('.story:not([style*="display: none"])').length;
  countEl.textContent = visible + ' of ' + stories.length + ' stories';
}

buttons.forEach(function(btn) {
  btn.addEventListener('click', function() {
    buttons.forEach(function(b) { b.classList.remove('active'); });
    btn.classList.add('active');
    var theme = btn.getAttribute('data-theme');
    stories.forEach(function(s) {
      s.style.display = (theme === 'all' || s.getAttribute('data-theme') === theme) ? '' : 'none';
    });
    updateCount();
  });
});
updateCount();
</script>

</body>
</html>
